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 Endothelial dysfunction has been shown to be an important precursor in the 
atherosclerotic process (Bonetti, Lerman & Lerman, 2003; Ras et al., 2013; Ross, 1993, 
Ross, 1999; Vita & Keaney Jr, 2002). An association of endothelial dysfunction with 
increasing age (Celermajer et al., 1994), gender (Juonala et al., 2008; Kapuku et al., 
2004), cigarette smoking (Lekakis et al., 1998), and obesity (Tounian et al., 2001; 
Williams et al., 2005) has been reported. 
 A widely used method of assessing endothelial function is flow-mediated dilation 
(FMD) (Celermajer et al., 1992; Corretti et al., 2002; Ras et al., 2013). This method of 
vascular health assessment utilizes ultrasound imaging and has historically focused on the 
degree of vessel dilation in response to reactive hyperemia to ascertain endothelial 
function (Corretti et al., 2002; Flammer et al., 2012; Harris et al., 2010; Thijssen et al., 
2011). The response of differing vascular beds, such as radial (Jiang et al., 2011), 
brachial (Corretti et al., 2002) and femoral (Kooijman et al., 2008) arteries, have been 
investigated with FMD assessment. All three vascular beds display nitric oxide-mediated 
responses (Doshi et al., 2001; Joannides et al., 1995 Kooijman et al., 2008), but the 
brachial artery’s ideal location (easily accessible) and vessel diameter makes it the 
preferred site of assessment (Charakida et al., 2010).  
A strong correlation between endothelial function in coronary and brachial 
arteries has been reported (Takase et al., 1998) which allows brachial FMD to be a 
surrogate measure of coronary function. Also, many studies have shown impairment of 
FMD in response to a range of cardiovascular risk factors (Maruhashi et al., 2013; Ras et 
al., 2013; Yang et al., 2014) and FMD has been inversely associated with future CVD 
  3 
events (Brevetti et al., 2003; Katz et al., 2005; Muiesan et al., 2008; Ras et al., 2013; 
Rossi et al., 2008). However, specifically in the brachial and radial arteries, a biphasic 
response, where vessel constriction occurs prior to dilation, has been observed during 
reactive hyperemia (Dobrosielski et al., 2006; Jiang et al., 2011).  
The constriction phase during reactive hyperemia has been largely overlooked in 
FMD research. Recent research has examined a constriction effect of the radial vessel 
during distal occlusion termed low-flow-mediated constriction (L-FMC), and suggests its 
usefulness as an alternative measure of cardiovascular response to FMD (Dawson et al., 
2012; Gori et al., 2008; Gori et al., 2010; Humphreys et al., 2014; Harrison et al., 2011; 
Weissgerber et al., 2010). In contrast, little is known concerning a constriction of the 
vessel following distal occlusion (Dobrosielski et al., 2006; Jiang et al., 2011), termed 
high-flow-mediated constriction (H-FMC). Therefore, the purpose of the following 
dissertation was to perform a cross-sectional examination of children, adolescents and 
adults to quantify the frequency and magnitude of H-FMC, determine potential influences 
of sex, age, body composition, cardiovascular and metabolic factors on H-FMC, and 
report the reproducibility of an H-FMC in young adults. The findings of the present 
dissertation will lend additional insight to the existing body of research surrounding FMD 
assessment and quantify the initial brachial artery response to reactive hyperemia in 
humans. 
 The specific study aims arising from this dissertation are as follows: 
1.  Determine the reproducibility of an H-FMC in healthy young adults. 
a. Hypothesis 1: H-FMC in young adults will be highly reproducible and have 
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 similar intra- and inter-day reproducibility as FMD. 
2. Describe the frequency of H-FMC during reactive hyperemia in normal weight, 
overweight and obese children and adolescents. Also, investigate differences in 
FMD, hemodynamic and anthropometric measures between those subjects who 
experience this phenomenon and those who do not. 
 a. Hypothesis 1: H-FMC will be associated with lower peak FMD. If H-FMC is 
associated with lower peak FMD, and a decreased FMD is an indicator of 
endothelial dysfunction, then H-FMC may be considered detrimental. Normal 
weight children and adolescents will not display H-FMC. A majority of obese and 
overweight children and adolescents will present H-FMC.  
3.  Describe the frequency and magnitude of an H-FMC during reactive hyperemia in 
healthy adult males and females.  Additionally, examine the relationship of H-FMC 
to FMD, biomarkers of cardiovascular and metabolic risk as well as measures of 
body composition.  
 a. Hypothesis 1: H-FMC will be associated with lower peak FMD and will be 
significantly correlated with body composition as well as known cardiovascular and 
metabolic risk factors. 
 
 The second chapter of this dissertation will provide an extensive review of the 
existing literature on arterial vasoregulation. Specific mechanisms of vascular function 
will be described. FMD, L-FMC and H-FMC methodologies, along with commonly used 
calculations to quantify vascular function will be examined. Additionally, vascular 
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dysfunction associated with atherosclerosis, inflammation, body composition and 
hypercholesterolemia will be discussed. 
 The third chapter will evaluate whether an H-FMC response is reproducible 
within and between days in a population of young adults. Flow-mediated dilation has 
been shown to have very good reproducibility within and between days in an adult 
population. For H-FMC to be an ancillary measure of endothelial function and vascular 
health, it would be essential for an H-FMC to be highly reproducible in an individual. 
The reproducibility of an H-FMC in adults has never been studied, however, 
understanding the reproducibility could improve the methods of vascular health 
assessment. 
The fourth chapter will examine the presence and magnitude of an H-FMC prior 
to FMD in children and adolescents across a wide range of body mass indexes and 
percent body fat. No study has investigated the presence and magnitude of an H-FMC in 
children and adolescents. Obesity has been associated with negative influences on 
vascular physiology and there have been an increasing number of obese children and 
adolescents in the past half-century. The potential correlations of H-FMC to 
hemodynamic and body composition measures in children and adolescents will be 
evaluated. 
 The frequency and magnitude of H-FMC of the brachial artery in adults and the 
potential relationship of H-FMC with body composition, cardiovascular and metabolic 
risk factors will be examined in chapter five. To our knowledge, only one study has 
investigated H-FMC in the brachial artery in adult males, and to date, no studies have 
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investigated an H-FMC in adult males and females. Also, the inclusion of precise body 
composition, cardiovascular and metabolic measures has not been examined in 
association with H-FMC. 
 Finally, the sixth chapter will summarize each study and the significant 
observations will be reviewed. Future research involving H-FMC will be proposed. 
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Introduction 
 With such an overwhelming presence of CVD in the United States and the world 
(Kochanek et al., 2011; Mendis et al., 2011), there has been great interest in the 
mechanisms involved in the progression of CVD. Also, the advancement of early 
detection methods concerning CVD development has intensified in order to prevent 
future cardiovascular events. A substantial amount of research has specifically 
investigated the role of the endothelium in the progression of CVD (Bonetti, Lerman & 
Lerman, 2003; Ras et al., 2013; Ross, 1993; Ross, 1999; Vita & Keaney Jr, 2002).   
Vessel function is greatly affected by endothelial-derived substances, which are 
involved in a host of both pathological and physiological processes (Harris et al., 2010; 
Rubanyi, 1993; Vane, Anggard & Botting, 1990). Factors such as inflammation and body 
composition (Bray, 2004) can affect the release of endothelial-derived substances. When 
the homeostatic balance of endothelial-derived substances (i.e. relaxing and contracting 
factors) is disrupted, the vasculature is prone to leukocyte adhesion (Granger & 
Senchenkova, 2010), mitogenesis, thrombosis (Rubanyi, 1993), vascular inflammation, 
platelet activation (Landray et al., 2004), pro-oxidation, impaired coagulation (Goldberg, 
2009), vasoconstriction, and atherosclerosis (Davignon & Ganz, 2004; Grover-Paez & 
Zavalza-Gomez, 2009). Thus, the complexity of the endothelium and endothelial-derived 
substances makes it is difficult to define endothelial dysfunction. However, endothelial 
dysfunction generally refers to vascular reactivity, but can include an inflammatory and 
thrombotic component.  
Various techniques have been developed to evaluate endothelial function 
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(Brevetti, Schiano & Chiariello, 2008). However, a widely used, non-invasive method of 
assessing endothelial function is FMD (Corretti et al., 2002; Harris et al., 2010; Thijssen 
et al., 2011;). L-FMC has been a proposed method complementing FMD for assessing 
endothelial function (Gori et al., 2008; Gori et al., 2010; Gori, Parker & Munzel, 2011). 
Interestingly, minimal attention has been given to the H-FMC response of the vasculature 
to reactive hyperemia (Dobrosielski et al., 2006; Jiang et al., 2011). Recently, the 
statistical analysis and reporting of FMD and L-FMC as a percent change from a baseline 
diameter has been challenged (Atkinson & Batterham, 2015; Atkinson & Batterham, 
2013). Allometric scaling has been suggested as a way to appropriately quantify a 
biological change (Atkinson & Batterham, 2015). 
 The following literature review will first describe the mechanisms of vascular 
function, and then briefly discuss the relationship of endothelial dysfunction and specific 
CVD risk factors. Finally, the history and methodologies of FMD, L-FMC and H-FMC 
will be discussed along with the current debate of allometric scaling.   
 
Mechanisms of Vascular Function 
 The flow of blood through the peripheral arteries is controlled by a number of 
components, such as pressure, viscosity and vessel diameter (Kenney, Wilmore & Costill, 
2015). The changing of a vessel diameter through constriction or relaxation of the smooth 
muscle is essential for appropriate distribution of nutrients and removal of waste. Local 
metabolites sensed by chemoreceptors, pressure changes sensed by baroreceptors, and 
endothelial-derived substances all have the ability to affect vessel diameter (Kenney, 
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Wilmore & Costill, 2015). However, endothelial-derived substances will be the focus of 
the review, with a brief discussion of the myogenic response affecting vessel diameter.  
 
Myogenic Response 
 An important factor in blood flow regulation is the myogenic response of the 
vasculature. The definition of a myogenic response is the inherent ability of arterial 
vessels to response to changes in transmural pressure via diameter modification (Lott, 
Herr & Sinoway, 2002; Schubert & Mulvany, 1999). Specifically, an increase in pressure 
across the arterial wall produces smooth muscle contraction while decreased pressure 
produces relaxation (Kenney, Wilmore & Costill, 2015). This mechanism is independent 
of endothelial (Ekelund et al., 1992; Falcone, Davis & Meininger, 1991) and neural 
effects (Folkow, 1949; Folkow, 1952). In limited human research, changes in transmural 
pressure produced changes in limb flow dynamics at rest and following muscle 
contraction without significant changes in diameter of the brachial artery (Lott, Herr & 
Sinoway, 2002; Shoemaker, Pozeg & Hughson, 1996). However, in the radial artery, 
initial changes in vessel diameter following occlusion have been attributed to changes in 
transmural pressure (Jiang et al., 2011).  
 
Endothelial-Derived Substances 
Vasodilation 
 The endothelium is a major contributor to vasoregulation, as it produces both 
vasoconstrictors and vasodilators. The vasodilating factors include: nitric oxide (NO), 
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prostacyclin, bradykinin, and endothelial-derived hyperpolarizing factor (EDHF) (Vogel, 
2001). Of the known vasodilators, NO is the primary factor (Furchgott & Zawadzki, 
1980; Palmer, Ferrige & Moncada, 1987). Furchgott and Zawadzki first discovered nitric 
oxide in 1980, using rabbit atrial vasculature and administration of acetylcholine (ACh) 
in vitro to produce smooth muscle relaxation. Initially termed as an endothelial-derived 
releasing factor (EDRF), this groundbreaking study demonstrated that for ACh to 
produce a vasodilatory response in vitro, the presence of endothelium was required 
(Furchgott & Zawadzki, 1980). Subsequently, EDRF and NO were discovered to be 
synonymous (Moncada, Radomski & Palmer, 1988; Palmer, Ferrige & Moncada, 1987). 
The synthesis of NO involves nitrogen oxidation from L-arginine to produce L-citrulline 
and NO (Palmer, Ashton & Moncada, 1988) and this process is catalyzed by endothelial 
nitric oxide synthase (eNOS) (Forstermann & Munzel, 2006). There are two endothelial 
forms of NOS: constitutive NOS (cNOS) and inducible NOS (iNOS) (Klabunde, 2011). 
Nitric oxide is continually being produced by cNOS under normal, basal conditions, 
while iNOS activity is stimulated during inflammation (Klabunde, 2011). Once produced, 
NO diffuses to the vascular smooth muscle to activate vasodilation through increases in 
cyclic guanosine monophosphate (cGMP) (Deanfield, Halcox & Rabelink, 2007; Vogel, 
2001). The presence of shear stress on the vessel wall is a vital activator of eNOS. At 
rest, low levels of NO are constantly released from the endothelium (Vallance, Collier & 
Moncada, 1989). However, when increased blood flow occurs, the elevated shear stress 
on the endothelium stimulates elevated NO formation through increased calcium release, 
thereby causing rapid smooth muscle vasodilation (Klabunde, 2011).  
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 Prostacyclin, a principle metabolite of arachidonic acid (Moncada et al., 1976; 
Moncada & Vane, 1979), acts independently of NO and has limited involvement in the 
vasodilator response (Deanfield, Halcox & Rabelink, 2007). Bradykinin also has a 
secondary effect in vasodilation by stimulating specific endothelial β2 receptors, which 
cause the release of prostacyclin (Barrow et al., 1986), NO (O’Kane, et al., 1994) and 
endothelial-derived hyperpolarizing factor (EDHF) (Hornig, Kohler & Drexler, 1997; 
Mombouli et al., 1992). Defined as a non-characterized endothelial factor, EDHF has 
been correlated to an intracellular concentration of Ca
2+
 and membrane hyperpolarization 
in endothelial cells and vascular smooth muscle cells. When the membrane of vascular 
smooth muscle is hyperpolarized, a decrease in Ca
2+
 occurs which leads to relaxation 
(Johns et al., 1988; Luckhoff et al., 1988). 
 
Vasoconstriction 
 Known endothelium-derived contracting factors are endothelin, thromboxane and 
angiotensin II (Vogel, 2001). Of these contractile factors, endothelin, specifically 
endothelin-1 (ET-1), is the most potent (Van Guilder et al., 2007). ET-1 is a 21-amino 
acid peptide (Yanagisawa et al., 1988) that is produced through the conversion of a 39-
amino acid precursor by an endothelin converting enzyme (ECE) (Klabunde, 2011). ET-1 
is released from the endothelium and binds to adjacent smooth muscle membrane 
receptors. The binding of ET-1 causes an increase in Ca
2+
 release by way of a 
phospholipase C-inositol triphosphate pathway (Luscher & Barton, 2000; Miyauchi & 
Masaki, 1999; Van Guilder et al., 2007) and produces smooth muscle contraction. Of 
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interest, ET-1 can stimulate NO production when binding to endothelin receptors found 
on the endothelium (Figure 1) (Klabunde, 2011). Endogenous production of ET-1 
contributes to the maintenance of basal vascular tone (Haynes & Webb, 1994). However, 
increased ET-1 production can instigate oxidant stress leading to endothelial dysfunction 
and vascular remodeling (Amiri et al., 2004). 
 
Figure 1. Endothelin Receptors and Interactions with Nitric Oxide 
 
Adapted from Cardiovascular Physiology Concepts, 2
nd
Edition 
 
 Angiotensin II has a similar effect, albeit not as potent, as ET-1 by causing a 
cascade effect via G protein signaling on the vascular smooth muscle. The G-protein 
signaling pathway promotes Ca
2+
 release and subsequent constriction (Mehta & 
Griendling, 2007). Thromboxane is similar to prostacyclin, in that it is formed from 
arachidonic acid. However, thromboxane has been shown to have a contractile effect on 
  14 
vascular smooth muscle (Dusting, Moncada & Vane, 1978). Many of the endothelium-
derived contracting factors have an inhibitory effect on endothelium-derived relaxing 
factors, and vice versa. 
 There is a synergistic approach to maintain vascular tone. Of the previously 
discussed endothelial-derived vasoactive substances, the primary factors in vasomotor 
control are NO and ET-1. At rest and in the absence of sympathetic nerve activity, 
myogenic contraction of smooth muscle in response to pressure (Davis & Hill, 1999) and 
NO release from the endothelium (Davies, 1995) maintain vascular tone (Thomas & 
Segal, 2004).  
 
Endothelial Dysfunction and Risk Factors 
 The endothelium performs a multitude of actions through the production of many 
vasoactive factors. When the homeostatic balance of endothelial-derived relaxing and 
contracting factors is disrupted, the vasculature is prone to leukocyte adhesion (Granger 
& Senchenkova, 2010), thrombosis, vascular inflammation, platelet activation (Landray 
et al., 2004), pro-oxidation, impaired coagulation (Goldberg, 2009), vasoconstriction, and 
atherosclerosis (Davignon & Ganz, 2004; Grover-Paez & Zavalza-Gomez, 2009). Many 
cardiovascular and metabolic disorders and risk factors appear to be in conjunction with 
endothelial dysfunction (Forstermann & Munzel, 2009). The association between 
endothelial dysfunction with inflammation, atherosclerosis, obesity and 
hypercholesterolemia will be discussed. 
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Inflammation 
 It has been hypothesized that endothelial dysfunction could be linked to increased 
inflammatory responses (Grover-Paez & Zavalza-Gomez, 2009). A number of 
observational studies have described an association of inflammation and CVD risk (Ross, 
1999; Stenvinkel, 2001). Specifically, endothelial exposure to pro-inflammatory 
cytokines can increase adhesion molecules on the endothelial cells (Alexander, 1995) and 
impair endothelial-dependent dilation (Bhagat & Vallance, 1997). These cytokines could 
be present from obesity (Anderson, Rahmutula & Gardner, 2004; Wassman et al., 2004), 
diabetes, or smoking (Barbieri et al., 2011; Jefferis et al., 2010; Wannamethee et al., 
2005) and can lead to atherosclerosis. A common serum measure of inflammation, C-
reactive protein (CRP), has been inversely correlated with forearm blood flow response 
to acetylcholine (Fichtlscherer et al., 2000). Interestingly, when CRP levels were 
decreasing over a 3-month period, endothelial-dependent forearm blood flow-responses 
normalized (Fichtlscherer et al., 2000). It has also recently been observed that CRP levels 
are inversely related to basal endothelial nitric oxide synthesis (Cleland et al., 2000). This 
response is not limited to CHD patients (Fichtlscherer et al., 2000; Sinisalo et al., 2000), 
but also occurs in healthy adults (Cleland et al. 2000).  
 Research concerning inflammation and CVD risk is not limited to observational 
studies. On the contrary, experimental studies have yielded valuable information 
concerning an inflammation and endothelial dysfunction relationship. One study 
particularly elicited a temporary, mild inflammatory response to a Salmonella typhi 
vaccine to produce profound endothelial dysfunction of the arterial vasculature in 12 
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healthy adults (Hingorani et al. 2000). These findings suggest that an important 
component in the relationship between low-grade chronic inflammation and CVD is 
endothelial dysfunction (Grover-Paez & Zavalza-Gomez, 2009). 
 
Atherosclerosis 
 The combination of inflammation and endothelial dysfunction has been 
considered a significant precursor to atherosclerosis (Grover-Paez & Zavalza-Gomez, 
2009). Laminar shear stress generates a mean positive shear stress on the endothelium 
and is essential for normal endothelial activation and reorientation (Dewey et al., 1981; 
Flaherty et al., 1972; Traub & Berk, 1998). However, when low mean shear stress and 
oscillatory shear stress (i.e. periodic flow reversal with time-averaged shear stress 
approaching zero) occur, endothelial cells do not reorient (Davies et al., 1986) and could 
encounter high shear gradients (Davies, 1995). Oscillatory and low mean shear stress 
conditions are responsible for atherosclerotic lesions, plaque formation and plaque 
vulnerability (Asakura & Karino, 1990; Ku et al., 1985; Traub & Berk, 1998) and can 
increase ET-1 expression along with decreasing eNOS expression (Grover-Paez & 
Zavalza-Gomez, 2009). The increase in ET-1 may lead to vascular inflammation, as ET-1 
is associated with pro-inflammatory cytokines like tumor necrosis factor α (TNF-α) and 
interferon-γ (IFN-γ) (Klemm et al., 1995; Saleh et al., 1997). Endothelin-1 also promotes 
excessive oxidative stress (Dong et al., 2005), induces adhesion molecules on endothelial 
cells (Zouki et al., 1999), and mediates nuclear factor-kB (NF-kB) in monocytes (Grover-
Paez & Zavalza-Gomez, 2009). 
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 A normal functioning endothelium does not support binding of white blood cells 
(Grover-Paez & Zavalza-Gomez, 2009). When NO is being regularly produced in 
response to laminar shear stress, the anti-inflammatory properties of NO can limit the 
expression of vascular cell adhesion molecule-1 (VCAM-1) on the endothelium. 
However, augmented production of leukocyte adhesion molecules is experienced during 
disturbed blood flow. VCAM-1 tends to bind to leukocytes found in atheroma, or the 
fatty material of plaque (Cheng et al., 2006; Cybulsky et al., 2001; Grover-Paez & 
Zavalza-Gomez, 2009; Ishizuka et al., 1999). These endothelial-bound leukocytes will 
enter the intima and propagate a localized inflammatory response thought to precede 
atherosclerosis.  The leukocytes present receptors for low-density lipoproteins to oxidize 
and lead to foam cell formation (Aviram, 1999). With advanced foam cell formation and 
enhanced pro-inflammatory cytokine presence (TNF-α and IFN-γ), the release of a 
variety of peptide growth factors can promote the formation of a dense extracellular 
matrix that is observed in advanced atherosclerosis (Grover-Paez & Zavalza-Gomez, 
2009). This plaque may be localized along one segment of the arterial vasculature or 
circumferentially (Verstraete, 1990). A hard, calcified plaque would be predominantly 
fibrotic, while a soft plaque would mainly contain cholesterol-esters and foam cells 
(Verstraete, 1990). The soft plaque generally has a thin fibrous cap that is more prone to 
rupture from increased shear stress. Once a fibrous cap has been dislodged, it may 
develop into a thrombus causing an embolism. Depending on the location of the 
embolism, stroke (Arenillas, 2011), myocardial ischemia and infraction, or death could 
occur (Verstraete, 1990). 
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Obesity 
 Once considered merely an effecter of healthiness and beauty, obesity is now 
classified in the same chronic disease stratum as hypertension and atherosclerosis 
(Avogaro & de Kreutzenberg, 2005; Bray, 2004) and has been correlated to 
cardiovascular risk factors (Avogaro & de Kreutzenberg, 2005; Stern, 1995). Recently, 
the regional distribution of fat has been of interest in morbidity and mortality rates.  
Excessive accumulation of fat in the abdominal region, i.e. central obesity, has been 
reported as being a better predictor of morbidity and an independent risk factor for 
coronary heart disease (CHD) (Avogaro & de Kreutzenberg, 2005; Clark et al., 1994; 
Hodgson et al., 1994; Kaplan, 1989; Kortelainen, 1996). Also, the relationship between 
CHD and obesity is not limited to older adults, but has been reported in children and 
adolescents (Must et al., 1992; Nieto, Szklo & Comstock, 1992).  
Since adipose tissue has secretory properties, it has the ability to significantly 
affect the endothelial function. Some of the prominent adipokines, or proteins secreted by 
adipocytes, are leptin, resistin, interleukin (IL) 6, and TNFα (Avogaro & de 
Kreutzenberg, 2005). Leptin is the main protein that is released by adipocytes and it has a 
significant spectrum of effects on vascular homeostasis (Correia & Haynes, 2004). 
Considering endothelial function, leptin has been shown to cause oxidative stress in vitro 
by increasing reactive oxygen species (ROS) generation (Bouloumie et al., 1999). 
Increased pro-inflammatory cytokine secretions, such as TNFα and IL-6, can also be 
stimulated by leptin and affect endothelial function (Bullo et al., 2003; Chu, Chang & 
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Shieh, 2003). Another adipokine, resistin, has been correlated with the development of 
insulin resistance, obesity (Steppan et al., 2001), and modified endothelial function 
(Verma et al., 2003). An increase in ET-1 was observed in endothelial cells that were 
incubated with human recombinant resistin without a significant change in NO 
production (Verma et al., 2003). Also, VCAM-1 expression was elevated in resistin-
treated endothelial cells, suggesting that resistin promotes ET-1 release from endothelial 
cells and an upregulation of adhesion molecules (Avogaro & de Kreutzenberg, 2005).  
 Adipose tissue, specifically visceral adiposity, seems to be a prime regulator of 
inflammation through direct secretion of pro-inflammatory cytokines. When pro-
inflammatory cytokines are released from adipose tissue, they can influence both glucose 
metabolism and endothelial function (Yudkin, 2003). Adipose tissue is able to stimulate 
nuclear transcription factor-kappa B (NFκB) by releasing TNFα. NFκB is essential in an 
inflammatory and apoptotic response by regulating growth factor expression, pro-
inflammatory cytokines and adhesion molecules (Mercurio & Manning, 1999). Studies 
have demonstrated that TNFα released from adipose tissue increases endothelial 
permeability (Dodd-O et al., 2004) and inhibits eNOS gene expression enough to account 
for the displayed endothelial dysfunction (Anderson, Rahmutula & Gardner, 2004). Thus, 
TNFα generates oxidative stress that can lead to endothelial dysfunction and 
atherosclerosis.  
IL-6 also has negative effects on the endothelium (Avogaro & de Kreutzenberg, 
2005) and is associated with obesity (Yan et al., 1997). Wassman and colleagues (2004) 
reported that endothelial dysfunction could be induced by IL-6 through the upregulation 
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of an angiotensin II receptor that may contribute to the oxidative stress caused by obesity. 
Also, IL-6 from abdominal fat deposits has been observed to stimulate increases in CRP 
production in the liver and elevate plasma CRP concentrations (Niskanen et al., 2004). It 
has been postulated that abdominal obesity could help explain the inflammatory reaction 
observed in an obese population (Niskanen et al., 2004), since a significant relationship 
has been found between plasma CRP concentrations and BMI, total body fat mass and 
waist measurements (Pasceri, Willerson & Yeh, 2000). When endothelial cells are 
exposed to CRP, NO production is reduced due to the decreased eNOS mRNA stability 
and downregulation of eNOS gene expression (Ikeda, Takahashi & Shimada, 2003). In 
summary, obesity has various, interrelated inflammatory effects on endothelial function 
and NO production. 
 
Hypercholesterolemia 
 Cholesterol is a well-established risk factor for coronary artery disease 
development (Grover-Paez & Zavalza-Gomez, 2009). Elevated blood cholesterol levels, 
i.e. hypercholesterolemia (Williams, Anderson & Rawson, 2013), have been correlated to 
abnormal endothelial function in humans (Chowienczyk et al., 1992; Creager et al., 1990; 
Drexler & Zeiher, 1991; Sorensen et al., 1994). Of interest, hypercholesterolemic 
individuals have been reported to display vasoconstriction with an intracoronary infusion 
of acetylecholine, which is contrary to the vasodilatory response observed in individuals 
with an intact endothelium (Zeiher et al., 1991). However, total serum cholesterol levels 
and endothelial function may not be significantly correlated (Landmesser, Hornig & 
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Drexler, 2000). Instead, high-density lipoprotein (HDL)-cholesterol may be an important 
measure in determining endothelial function in hypercholesterolemia patients, 
specifically for the presumed protective function of HDL-cholesterol (Tall, 1990). 
Moreover, the low-density lipoprotein value has less of a determining factor in the degree 
of endothelial dysfunction compared to the LDL/HDL ratio, indicating a possible 
protective effect of HDL on endothelial function (Drexler et al., 1992).  
 The specific mechanism by which impairment of endothelium-dependent 
vasodilation occurs in hypercholesterolemia individuals is mainly due to a decrease in 
NO bioavailability (Landmesser, Hornig & Drexler, 2000). Hypercholesterolemia has 
been proposed to correlate to excessive oxidative stress, specifically endothelial 
superoxide anion generation.  The three major sources of increased superoxide anion 
generation in hypercholesterolemia are: the vascular NADPH oxidase, the xanthine 
oxidase, and the “uncoupled” NO synthase (Landmesser, Hornig & Drexler, 2000). In 
hypercholesterolemic rabbits, an increased vascular NADPH oxidase activity has been 
reported (Warnholtz et al., 1999) as well as increased circulating plasma xanthine oxidase 
contributing to vascular dysfunction (White et al., 1996). Also, an in vitro study revealed 
LDL could cause an uncoupling of eNOS that then generates superoxide anions 
(Pritchard et al., 1995). Excessive superoxide generation could not only effect NO 
production, but also could increase LDL oxidation and further promote endothelial cell 
damage through peroxynitrite and hydroxyl radical generation (O’Brien et al., 1997). 
Elevated plasma lipid peroxidation markers have been closely related to plasma 
cholesterol concentrations in hypercholesterolemic patients (Reilly et al., 1998), with 
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oxidized LDL level, specifically, being inversely related to endothelium-dependent 
vasodilation (Heitzer et al., 1996). 
 Research in animal models has supported the importance of antioxidants to 
maintain endothelium-dependent vasodilation. The administration of superoxide 
dismutase in hypercholesterolemic rabbits has been demonstrated to restore endothelium-
dependent vasodilation (Mugge et al., 1991). Also, dietary antioxidants have been shown 
to preserve vessel relaxation (Keaney et al., 1993). In humans, improved endothelium-
dependent vasodilation has been observed in hypercholesterolemic patients following 
administration of alpha-tocopherol (vitamin E) (Neunteufl et al., 1998) and ascorbic acid 
(vitamin C) (Ting et al., 1997). Of interest, the treatment of endothelin receptor 
antagonists has been reported to improve coronary endothelium-dependent vasodilation 
in hypercholesterolemic pigs (Best et al., 1999). Finally, the lowering cholesterol levels 
in patients with coronary artery disease can decrease rates of myocardial infarction and 
improve endothelial function (Grover Paez & Zalvalza-Gomez, 2009).   
 In summary, the presence of cardiovascular risk factors leads to endothelial cell 
disturbance, which can cause vascular remodeling and endothelial dysfunction. At the 
center of endothelial dysfunction is oxidative stress. Increased levels of reactive oxygen 
species, brought about by any number of risk factors, could cause a cascade effect that 
seems to focus on the interaction with NFκB. Increased activation of NFκB could 
decrease eNOS transcription and NO production while increasing TNFα and oxidation of 
LDLs. Figure 2 illustrates this interaction. 
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Figure 2. Indicators of Endothelial Dysfunction in Cardiovascular Diseases 
 
 
Adapted from “Role of inflammatory cytokines in endothelial dysfunction” (Zhang, 2008) 
 
Endothelial Assessment Techniques 
 Endothelial dysfunction undoubtedly contributes to the progression of 
atherosclerosis (Verma & Anderson, 2002). About 27 million individuals in North 
America and Europe are diagnosed with peripheral artery disease (PAD), a major 
manifestation of atherosclerosis (Belch et al., 2003).  Therefore, the ability to accurately 
assess endothelial function can provide valuable clinical information and possible insight 
into the effectiveness of a variety of therapeutic interventions. Various techniques have 
been developed to evaluate endothelial activation, dysfunction, and damage (Brevetti, 
Schiano & Chiariello, 2008). Ultrasound assessment of FMD is the most common 
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technique to measure endothelial function (Corretti et al., 2002; Harris et al., 2010; 
Thijssen et al., 2011). Recently, L-FMC (Gori et al., 2008) and H-FMC have been 
proposed to increase the accuracy of endothelial function assessment. 
 
FMD 
 In 1992, Celermajer et al. (1992) developed an approach to assess peripheral 
conduit artery diameter changes following distal limb ischemia. This technique was based 
on the relation between increases in blood flow, wall shear stress, endothelial NO 
synthases expression and NO bioactivity found in animal models (Berdeaux et al., 1994, 
Furchgott & Zawadzki, 1980; Tuttle et al., 2001). In humans, increases in flow-associated 
shear brought about by differing periods of arterial occlusion produced vasodilation in 
large peripheral arteries (Anderson & Mark, 1989; Sinoway et al., 1989). Subsequent 
studies confirmed that the FMD technique was NO dependent (Joannides et al., 1995; 
Lieberman et al., 1996; Mullen et al., 2001), although a majority of these studies were 
performed on the radial vasculature. Currently, the brachial artery is the most common 
site for FMD assessment (Corretti et al., 2002; Harris et al., 2010; Thijssen et al., 2011). 
 The FMD technique has become the most utilized and widely accepted form of 
non-invasive endothelium-mediated vascular reactivity assessment (Flammer et al., 
2012), with over 3500 publications reporting FMD as a study outcome (Atkinson & 
Batterham, 2015). Utilizing an ultrasound probe, FMD assessment consists of the 
analysis of captured images of the brachial artery following 5-minutes of blood flow 
occlusion at the forearm with a sphygmomanometer cuff (Corretti et al., 2002; Harris et 
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al., 2011). It is important to identify clear vascular boundaries, specifically the intima to 
intima (Harris et al., 2010), in the longitudinal plane of the vessel (Corretti et al., 2002; 
Thijssen et al. 2011). Following image capturing, edge-detection and wall-tracking 
software is recommended for image analysis to maintain validity and reproducibility 
compared to a manual assessment (Thijssen et al., 2011).  
Blood flow and velocity measurements are also collected during an FMD 
assessment via Doppler and can be used to calculate shear stress (Harris et al., 2010). It is 
recommended that a 60° angle between the Doppler beam and the vessel orientation is 
maintained along with optimal B-mode imaging to ensure measureable Doppler shifts 
(Thijssen et al. 2011). An increase in shear stress via reactive hyperemia has been thought 
to initiate eNOS production of NO, thereby causing brachial artery vasodilation (Corson 
et al., 1996; Pyke & Tschakovsky, 2005). Elevated levels of laminar shear stress have 
been observed to induce endothelial atheroprotective gene expression (Topper et al., 
1996).  
Historically, the important measure of reactive hyperemia has been peak FMD, 
which is reported as the largest artery diameter following occlusion compared to a 
baseline brachial artery diameter (Celermajer, et al., 1992; Corretti et al., 2002). In the 
original study (Celermajer et al., 1992), baseline diameter was defined as a pre-occlusion 
artery diameter, which has been the most frequently reported baseline in FMD literature 
(Lind, 2007; Pohl et al., 1986; Pyke, Hartnett & Tschakovsky, 2008; Sonka, Liang & 
Lauer, 2002; Thijssen et al., 2011). However, recent studies have investigated a baseline 
diameter during cuff inflation (Dawson et al., 2008; Magen et al., 2005; Malik, 
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Kondragunta & Kullo, 2008; Mullen et al., 2001; Neunteufl et al., 2000), claiming that 
restoration of an occlusion-induced change in vessel diameter is an important part of the 
FMD response itself. Although, the typical age-related reduction in FMD was not found 
when an occlusion baseline diameter was used (Preik et al., 2000), so a pre-occlusion 
brachial artery baseline diameter is traditionally recommended (Corretti et al., 2002; 
Thijssen et al., 2011). In the first studies using FMD, peak diameter was determined from 
a single frame at 60 seconds post occlusion (Celermajer et al., 1994; Celermajer et al., 
1992). However, recent papers have questioned the validity of this time point for 
detection of a true peak diameter (Black et al., 2008; Thijssen et al., 2008). A 25-40% 
underestimation of true maximal FMD can result from a predetermined time point 
calculation (Black et al., 2008; Thijssen et al., 2008). Thus, a continuous measurement of 
arterial diameter response during FMD testing has been suggested (Thijssen et al., 2011) 
due to the differences in time to peak diameter between (Black et al., 2008; Liuni et al., 
2010; Padilla et al., 2009) and within (Irace et al., 2008) groups to avoid type II statistical 
errors (Liuni et al., 2010; Thijssen et al., 2011).  
Results from brachial artery FMD have been shown to correlate with coronary 
artery endothelial function and have been deemed appropriate to be used as a surrogate 
measure (Takase et al., 1998). In general, there is a positive correlation between 
endothelial health and flow-mediated vasodilation. Impaired FMD response of the 
brachial artery has been considered a quantitative representation of endothelial 
dysfunction and may be a predictor of cardiovascular events (Deanfield, Halcox & 
Rabelink, 2007; Yeboah, et al., 2009). Generally, FMD has been safely applied to large 
  27 
groups of people across a wide age range (Celermajer et al., 1992; Leeson et al., 1997) 
and has also been repeated over time to measure longitudinal changes in vascular 
function (Quinton, Cook & Peek, 2007). 
   
L-FMC 
While FMD examines the ability of an artery to dilate in a hyperemic state, L-
FMC investigates the ability of the vasculature to constrict when blood flow is attenuated. 
Levenson, Simon & Pithois-Merli (1987) first described an in vivo brachial artery 
vasoconstriction response to acute reduction of blood flow via a supra-systolic wrist cuff. 
Later, forearm cuff occlusion for 10 minutes was found to induce a significant 
vasoconstriction of the brachial artery due to “circulatory arrest” or “low-flow” 
(Anderson & Mark, 1989; Humphreys et al., 2014). Recently, a proposed method of 
evaluating the acute response to blood flow occlusion in the radial artery was presented 
by Gori and colleagues (2008). Similar to FMD methodologies, L-FMC assessment 
utilized ultrasound technology to image the radial artery diameter after 5 minutes of a 
distal, supra-systolic cuff occlusion at the wrist. However, L-FMC has also been 
investigated at the brachial artery during an FMD procedure (Spiro et al., 2011; Stadler, 
Ibrahim & Lees, 1998; Thijssen et al., 2008). The calculation of L-FMC is similar to peak 
FMD calculation – as a relative change in diameter in relation to a baseline diameter 
(Gori et al., 2008). It was postulated that a reduced diameter during conditions of low-
flow could be principally linked to basal tone (Gori et al., 2008; Gori, Parker & Munzel, 
2011). Also, L-FMC may complement FMD by allowing for the description of basal and 
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stimulated vascular function (Gori, Parker & Munzel, 2011). 
The mechanisms involved in L-FMC have been thought to include increased 
vasoconstriction and/or decreased vasodilation factors released from the endothelium. In 
vivo evidence has been provided for L-FMC to be partly mediated though the 
endothelium (Dawson et al., 2012; Humphreys et al., 2014). Unlike FMD, which is an 
NO-mediated response, L-FMC was not altered by infusion of NO-blocker NG-
monomethly-L-arginine but was affected by inhibition of EDHF and prostaglandins  
(Gori et al., 2008). An abolished L-FMC response of the radial artery was found with the 
use of an ET-1 blockade, supporting the notion of an L-FMC produced via increased 
vasoconstrictor stimulation (Spieker, Luscher & Noll, 2003). However, changes in 
plasma ET-1 levels were not found to have an effect on L-FMC at the brachial artery 
(Spiro et al., 2011). Thus, the understanding of the mechanisms involved in L-FMC 
remains unclear. 
L-FMC can be measured concurrently with FMD at the brachial artery, which 
might provide additional and relevant information for interpretation of FMD (Gori, 
Parker & Munzel, 2011). There is observed heterogeneity in the response to low blood 
flow at the brachial artery, as healthy subjects have shown increased (Thijssen et al., 
2008), decreased (Spiro et al., 2011) or no diameter changes (Stadler, Ibrahim & Lees, 
1998). Weissgerber et al. (2010) examined L-FMC at the brachial and radial artery of 
pregnant and non-pregnant women and confirmed the presence of L-FMC at the radial 
artery, but no such response at the brachial artery. The heterogeneity of artery responses 
to low-flow has some implications for L-FMC use as a surrogate for the coronary 
  29 
arteries. However, those with CVD risk factors have displayed both diminished (Harrison 
et al., 2011) and improved (Stadler, Ibrahim & Lees, 1998) L-FMC responses at the 
brachial artery. Interestingly, the use of a composite end point (FMD + L-FMC) at the 
radial artery has been shown to improve detection of endothelial dysfunction in already 
diagnosed patients (Gori et al., 2010). This limited and conflicting evidence requires 
further research to understand the underlying stimuli of L-FMC and quantify the 
heterogeneity between arteries so correct interpretation of L-FMC can be performed. 
 
H-FMC 
 During an FMD procedure, an increase in shear stress via reactive hyperemia is 
experienced following 5-minutes of blood flow occlusion (Corretti et al., 2002; Harris et 
al., 2010; Thijssen et al., 2011). Immediately following occlusion cuff release, some 
arteries have displayed a constriction response to increased blood flow (Dobrosielski et 
al., 2006; Jiang et al., 2011), termed high-flow-mediated constriction (H-FMC). This 
opposing vasoconstrictor response conceals a shear stress-induced NO-mediated dilation 
of the artery (Dobrosielski et al., 2006; Jiang et al., 2011). A concealed or blunted 
dilatory response to shear stress could be interpreted as a marker of endothelial 
dysfunction. It is postulated that the observed vasoconstriction could result from an 
increase in ET-1 release and/or decrease in transmural pressure (Dobrosielski et al., 2006; 
Jiang et al., 2011; Kuchan & Frangos, 1993). A structural difference, i.e. degree of 
arterial stiffness, has also been postulated (Dobrosielski et al., 2006). Currently, limited 
research has investigated this constriction phenomenon following blood flow occlusion at 
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the brachial (Dobrosielski et al., 2006) and radial artery (Jiang et al., 2011). 
 
Endothelial Assessment Analysis 
Allometric Scaling 
 Since the technique of brachial artery FMD was first introduced (Celermajer et 
al., 1992), most of the 3500 publications have reported a conventional representation of 
FMD – as %Δ and/or mmΔ (Atkinson & Batterham, 2015; DeVan et al., 2013). However, 
several scaling and normalization adjustments have been suggested to improve 
sensitivity, accuracy and significance of FMD data (DeVan et al., 2013). Since FMD% is 
calculated as the difference between peak diameter and baseline diameter divided by 
baseline diameter and multiplied by 100, it is considered a ratio of peak diameter and 
baseline diameter (Atkinson et al., 2013). A ratio-approach to size-scaling a biological 
change is argued to not be appropriate (Atkinson & Batterham, 2013; Atkinson & 
Batterham, 2015; Packard & Boardman, 1999). Allometric scaling of vessel baseline 
diameter has been recently suggested to improve specificity of FMD for endothelial 
function and negate a ratio-approach of FMD reporting (Atkinson & Batterham, 2013; 
Atkinson et al., 2013). 
 Allometric scaling of baseline vessel diameter consists of logarithmically 
transforming the baseline diameter and peak diameter values, and deriving the change in 
diameter on the logged scale (Atkinson & Batterham, 2013). Then, the slope of the 
regression between the logarithmically transformed baseline diameter and peak diameter 
is calculated. If the slope is less than 1, peak diameter does not increase as a constant of 
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baseline diameter and inferences about differences in endothelial function based on 
FMD% might be unreliable (Atkinson & Batterham, 2013). If this is the case, diameter 
changes on the logged scale are entered into an ANCOVA model, with change in 
diameter as the outcome and a log-transformed baseline diameter as a covariate 
(Atkinson & Batterham, 2013; Atkinson et al., 2013). Covariate-adjusted means for 
diameter change are then back-transformed to provide a baseline-adjusted ratio of peak 
diameter and baseline diameter. An adjusted percentage change, or “corrected FMD%” 
could then be reported by taking the baseline-adjusted changes in diameter and 
subtracting a value of 1 and then multiplying by 100 (Atkinson & Batterham, 2013; 
Atkinson et al., 2013). This new approach to size-scaling the FMD response has been 
found to alter study inferences (Atkinson & Batterham, 2013; Atkinson & Batterham, 
2013). 
 There has been substantial debate over allometric scaling of FMD measurements. 
While some agree with the premise of the argument of Atkinson and Batterham (Stoner, 
Faulkner & Sabatier, 2013; Woodman & Mangoni, 2013), there are several factors to 
consider. First, the criteria for allometric scaling are not consistently met (DeVan et al., 
2013). For intervention and repeated measures studies, FMD is measured in the same 
way and adjusting for baseline will matter little, since any incurred bias should be 
balanced out within each individual across the study (Woodman & Mangoni, 2013). 
Since FMD research does not consistently meet the criteria for allometric scaling, it could 
be argued that allometric scaling provides little additional value. Second, allometric 
scaling of baseline diameter has been discovered to weaken the relationship between 
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FMD response and CVD large study populations, specifically in the Multi-Ethnic Study 
of Atherosclerosis (Atkinson & Batterham, 2013). This lack of relationship between 
FMD response and CVD is argued to miss a possible physiological link between larger 
vessels, low FMD response, and CVD (Mheid & Quyyumi, 2013). Third, there is no 
evidence that scaling the FMD values is predictive of incident events or diseases, but 
conventional brachial artery FMD values does have empirical evidence (DeVan et al., 
2013; Seals, Jablonski & Donato, 2011; Yeboah et al., 2009).  
Finally, Atkinson and Batterham (2013) present additional “corrected FMD” 
results to Celermajer and colleagues (1992) original research from differing vascular beds 
and reported equivalent FMD% across vascular beds. However, the assumption that 
differing vascular beds should provide equivalent FMD% (Atkinson & Batterham, 2013) 
may be misleading if there are vascular differences in structural composition, vasomotor 
tone, shear stress and endothelial function (Stoner, Faulkner & Sabatier, 2013). 
Interestingly, arterial wall structural differences are present in varying parts of the 
vasculature (Caro, 2012). Vasomotor tone is affected by transmural pressure and shear 
stress (Kelm & Schrader, 1990) and upper and lower limbs experience differing degrees 
of hydrostatic pressure and shear stress at rest (Newcomer et al., 2005). Also, endothelial 
function has been reported to be unequal between vascular beds (Newcomer et al., 2005; 
Thijssen et al., 2011; Stoner et al., 2006). 
Allometric scaling may prove to be an important addition to the traditional 
approach of FMD reporting. Currently, adopting an allometrically scaled FMD in 
conjunction with traditional FMD measures for cross-sectional studies could be 
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considered. The potential for enhanced sensitivity and validity of FMD with allometric 
scaling requires continuing research. 
 
Summary 
 The endothelium produces essential factors involved in vasomotor control. The 
disruption and disturbance of the endothelium and endothelial-derived factors can cause 
vascular remodeling and endothelial dysfunction via oxidative stress. Cardiovascular risk 
factors, such as obesity and hypercholesterolemia, can exacerbate the development of 
endothelial dysfunction and atherosclerosis. To detect and quantify endothelial function, 
FMD and L-FMC techniques have been proposed and developed. FMD via reactive 
hyperemia has been deemed the most accepted and utilized non-invasive technique for 
assessing endothelial function in healthy and at-risk populations. Historically, FMD has 
evaluated the peak dilatory response of an artery compared to a baseline diameter 
measure, while recent studies have quantified L-FMC and proposed new ways to scale 
the FMD response. However, studies investigating the H-FMC response to reactive 
hyperemia are lacking. The following dissertation evaluates the H-FMC response to 
reactive hyperemia in children, adolescents and adults and examines the reproducibility 
of the H-FMC response in young adults. 
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CHAPTER 3. INTRA- AND INTER-DAY REPRODUCIBILITY OF HIGH-
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Summary 
Purpose: Previously, we have demonstrated that high-flow-mediated constriction (H-
FMC) of the brachial artery has been shown to negatively affect flow-mediated dilation 
(FMD). However, the reproducibility of an H-FMC response is unknown. The aim of this 
study was to determine the intra- and inter-day reproducibility of H-FMC in young 
adults.  
Methods: Thirty young adults (15 male, 15 female; 24±3 years) were assessed for H-
FMC reproducibility via high-resolution ultrasound imaging of the brachial artery during 
and after forearm occlusion of a normal FMD procedure. Two vascular assessments were 
conducted for all participants during two separate visits with a minimum of 7-days in 
between. H-FMC was characterized as the greatest 10-second average constriction 
occurring after three seconds post occlusion compared to baseline brachial artery 
diameter and considered present if the percent change was less than -0.1%.  
Results: Of the 120 total vascular assessments performed in this study, 98 of the 
assessments (80.3%) displayed an H-FMC. H-FMC diameter was not statistically 
different for intra-day comparisons for visit 1 (P=0.39) or 2 (P=0.55) or inter-day 
comparisons between the first (P=0.61) or second (P=0.10) assessments. H-FMC 
percentage was also not statistically different for intra-day comparison for visit 1 
(P=0.94) or 2 (P=0.15) or inter-day comparisons between the first (P=0.63) or second 
(P=0.16) assessments.   
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Conclusion: These data are supportive of H-FMC being reproducible in young adults and 
included in future FMD studies. The impact of H-FMC on future CVD risk and 
development warrants evaluation.  
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Introduction 
 Endothelial dysfunction is a precursor in the development of atherosclerosis and 
cardiovascular disease (CVD) risk (Ross, 1999; Vita & Keaney Jr, 2002; Bonetti, Lerman 
& Lerman, 2003; Ras et al., 2013). A widely used method of assessing endothelial 
function is flow-mediated dilation (FMD) (Celermajer et al., 1992; Corretti et al., 2002; 
Ras et al., 2013), which utilizes ultrasound imaging of the brachial artery following acute 
reactive hyperemia. FMD has been inversely associated with future CVD events (Brevetti 
et al., 2003; Katz et al., 2005; Muiesan et al., 2008; Ras et al., 2013). Recently, during 
FMD measurement in the brachial artery, others and we have reported a biphasic 
response to reactive hyperemia, in which a vessel constriction phase occurs prior to a 
dilatory phase (Dobrosielski et al., 2006; Ostrem et al., 2015, Ostrem et al., 2016). This 
constriction phase during reactive hyperemia has been termed high-flow-mediated 
constriction (H-FMC). 
 Presently, we have reported approximately 67% of children and adolescents and 
69% of adults display an H-FMC during FMD assessment prior to a shear stress-
mediated dilation of the brachial artery (Ostrem et al., 2015; Ostrem et al., 2016). The 
presence of an H-FMC significantly reduced FMD response of the brachial artery to 
hyperemia compared to individuals without an H-FMC response when using a baseline 
diameter calculated during blood flow occlusion (Ostrem et al., 2015; Ostrem et al., 
2016). However, the reproducibility of brachial artery H-FMC has not been described.  
For H-FMC to be of value in assessing vascular function and as a potential biomarker of 
CVD it must be shown to be reproducible. Therefore, the aim of this study was to 
  39 
determine the intra- and inter-day reproducibility of H-FMC in healthy young adults 
(aged 18-30). We hypothesized that H-FMC in young adults will have an intra- and inter-
day reproducibility similar to the reported reproducibility of FMD in the brachial artery 
(Sorensen et al., 1995). 
 
Materials and Methods 
Study Population 
Thirty adults (15 males, 15 females) were assessed for the reproducibility of an H-
FMC. Subjects were recruited from the University of Minnesota and surrounding 
community and all subjects were free of known disease. The study protocol was reviewed 
and approved by the University of Minnesota Institutional Review Board and all 
participants gave written informed consent. The procedures followed were in accordance 
with the institutional review board and HIPAA guidelines. A total of four vascular 
assessments were performed per participant – two vascular assessments conducted during 
each of two separate visits (30 minutes: time between assessments each day), which were 
separated by a minimum of 7-days. Vascular assessments for each of the two visits were 
conducted during the same time of day, to avoid diurnal variation (Jarvisalo et al., 2006). 
Participants were instructed to fast for a minimum of 6 hours prior to each visit. It was 
recommended to ingest a similar meal prior to fasting for each of the two visits. Subjects 
were required to refrain from alcohol or caffeine ingestion within 6 hours prior to testing 
as well as avoid strenuous exercise or physical activity 24 hours prior to the study visit. 
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Physical Assessments 
Measurements for height and weight were obtained with a standard stadiometer 
and electronic scale (Cardinal Detecto, Model 758C, Webb City, MO, USA). Body mass 
index (BMI) was calculated as weight in kilograms (kg) divided by height in meters-
squared (m
2
).  
 
Vascular Assessments 
 Vascular testing was performed in the Vascular Laboratory in the Human 
Performance and Teaching Laboratory (HPTL) at the University of Minnesota. Subjects 
were tested in a quiet, climate-controlled room (22-23°C) by a single sonographer. 
Resting blood pressure was recorded using an automated sphygmomanometer (Colin BP-
8800, Colin Medical Instruments Corp., San Antonio, TX, USA) on the right arm prior to 
vascular assessment. A rapid-inflating occlusion cuff (D.E. Hokanson, Inc., Bellevue, 
WA) was also placed approximately five centimeters (cm) distal to the antecubital space 
on the left forearm. Following 10 minutes of quiet rest in the supine position, vascular 
images of the left brachial artery were obtained proximal to the antecubital fossa in the 
longitudinal plane using a conventional ultrasound scanner (Acuson, Sequoia 512, 
Siemens Medical Solutions USA, Inc., Mountain View, CA, USA) with a 8-15 MHz 
linear array probe held at a constant pressure on the skin and at a fixed point over the 
imaged artery by a stereotactic arm.  
Following resting vascular imaging, the Hokanson occlusion cuff on the left 
forearm was subsequently inflated to a suprasystolic pressure level of 200 mmHg and 
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maintained for 5 minutes. Vascular images were captured 20-seconds prior to cuff release 
until 3 minutes post-cuff release and were digitized and stored on a personal computer for 
later off-line analysis using an electronic wall-tracking software program (Vascular 
Research Tools 6, Medical Imaging Application, LLC, Iowa City, IA, USA). All subjects 
remained supine throughout the 30-minute interim between the first and second vascular 
assessment. The second vascular assessment was initiated with inflation of the left 
forearm cuff and conducted exactly as the first. Vascular images were analyzed for 
brachial artery baseline diameter, peak shear, maximal blood flow and brachial artery 
constriction.  The baseline brachial artery measurement was defined as a 10-second 
average just prior to release of the blood pressure cuff, i.e., occlusion baseline, to negate 
any low-flow mediated constriction that may occur during occlusion (Gori et al., 2008). 
Peak shear was used to estimate shear stress as a 10-second average during post occlusive 
reactive hyperemia, which was calculated as blood flow velocity (q) divided by arterial 
diameter (D). Maximal flow (m/s) was defined as the largest 10-second average rate of 
blood flow following cuff release. H-FMC was observed and characterized using a 10-
second average of the lowest point, (i.e. H-FMC diameter), from baseline brachial artery 
diameter following 3-seconds post cuff release and considered present if the percent 
change was less than -0.1% (H-FMC percentage) (Figure 1). All vascular analysis and 
interpretation was performed by a trained investigator who was blinded to study subjects 
and conditions. Image analysis and calculation of H-FMC was conducted for each subject 
once the final visit was completed to prevent biased interpretation. 
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 Statistical Analysis 
Statistical analysis was performed using IBM SPSS Statistics 22 (IBM Corp. 
Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM 
Corp.). Demographic characteristics for the population and vascular measurements are 
expressed as mean ± standard deviation (SD). Independent t-tests were conducted on 
gender differences for physical characteristics and blood pressure and heart rate 
measures. Paired t-tests were used to compare brachial artery baseline diameter, H-FMC 
measures, peak shear and maximum flow within each visit and between visit 1 and 2. A 
repeated measures ANOVA was conducted among all four vascular assessments for 
baseline diameter and H-FMC measurements. Greenhouse-Geisser F-statistic and 
significance were reported for within-subjects effects when statistical significance of 
assumed sphericity was present. An alpha value of 0.05 was denoted as statistically 
significant.  
Reproducibility of H-FMC was also assessed using a two-way agreement 
intraclass correlation coefficient (ICC) and coefficient of variation (CV) along with mean 
variation. Intraclass correlation coefficient comparisons were conducted between each of 
the two visits and within each visit for H-FMC diameter. Bland-Altman analyses were 
also performed to display the agreement between and within day for H-FMC diameter in 
our study population.  
Results 
 Mean demographic characteristics of young adults are presented in Table 1. The 
cohort ranged in age from 19 to 29 years old. As expected males had significantly greater 
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height, weight, BMI, systolic blood pressure (SBP), and heart rate compared to females. 
Of the 120 total FMD assessments performed in this study, 97 of the assessments (80.8%) 
displayed an H-FMC. Twelve subjects displayed an H-FMC during every FMD 
assessment and 15 subjects had an H-FMC in three of the four assessments. 
 Intra- and inter-day comparisons for variables of interest are included in Table 2. 
No statistically significant difference was found for any variable when intra- and inter-
day analysis was performed. Brachial artery baseline diameter was not different for intra-
day measures for visit 1 (P=0.36) and 2 (P=0.26). Inter-day measures of baseline 
diameter between the first (P=0.72) or second (P=0.06) procedures were also not 
significantly different. A repeated measures ANOVA produced no statistically significant 
variation for baseline diameter (P=0.24).  
Intra-day comparisons for peak shear were not significantly changed for visit 1 
(P=0.33) and 2 (P=0.47) or inter-day between the first (P=0.96) or second (P=0.87) 
assessments. Likewise, maximal flow was not different for intra-day measures within 
visit 1 (P=0.24) and 2 (P=0.36) or inter-day comparison between the first (P=0.89) or 
second (P=0.94) procedures. 
 H-FMC diameter was not changed for intra-day measurements within visit 1 
(P=0.39) and 2 (P=0.55). Inter-day measures of H-FMC diameter between the first 
(P=0.61) or second (P=0.10) procedures were also not significantly different. No 
statistically significant variation for H-FMC diameter was found when a repeated 
measures ANOVA was performed (P=0.334). H-FMC percentage was not significantly 
changed during intra-day comparison for visit 1 (P=0.94) or 2 (P=0.15) or inter-day 
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comparisons between the first (P=0.63) or second (P=0.16) assessments. No significant 
variation for H-FMC percentage was found when a repeated measures ANOVA was 
performed (P=0.511).  
The mean intra-day variation of H-FMC was -0.24±1.82%. The mean inter-day 
variation of H-FMC was -0.08±1.63%. The overall reproducibility of intra- and inter-day 
H-FMC diameter were ICC=0.98, CV=2.77% and ICC=0.96, CV=3.63%, respectively. 
These results as well as visual representation of the study protocol format are displayed in 
Figure 2. Bland-Altman plots (Figure 3) display acceptable agreement for intra- and 
inter-day H-FMC diameter assessment in our study population. 
 
Discussion 
 The aim of the present study was to determine the intra- and inter-day 
reproducibility of an H-FMC during vascular assessment in healthy, young adults. This 
study demonstrated that H-FMC is highly reproducible both intra- and inter-day. Also, 
peak shear and maximal flow, the primary stimuli for vasodilation, (Busse & Fleming, 
1998; Davies, 1995; Dimmeler et al., 1999; Kuchan & Frangos, 1994; Rubanyi, Romero 
& Vanhoutte, 1986) are consistent throughout intra- and inter-day vascular assessments.  
H-FMC diameter had greater variation (overall CV = 3.2%) compared to the 
reported reproducibility of FMD by Sorensen and colleagues (1995) (overall CV = 1.8%). 
However, the reported CV for H-FMC diameter in this study is still very good when 
compared to other FMD reproducibility studies (overall CV = 12.2%) (Ghiadoni et al., 
2012; Hijmering et al., 2001). Also, H-FMC had very good reproducibility when 
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including an ICC (overall ICC = 0.97), which was not reported in the FMD 
reproducibility study by Sorensen and colleagues (1995) but was similar to other reported 
correlation coefficients of FMD (ICC = 0.914) (Ghiadoni et al., 2012). Considering the 
intra- and inter-day ICC and CV of H-FMC diameter, an argument could be made to 
include the absolute vessel measure to quantify vascular change longitudinally and assess 
cross-sectional vascular health. H-FMC diameter may provide significant value in 
vascular health assessment similar to brachial artery baseline diameter or FMD, which 
has been inversely associated with CVD status (Yeboah et al., 2009). 
 Since vessel constriction and dilation percentage is contingent on the vessel 
baseline diameter (Corretti et al., 2002; Harris et al., 2010), it would be beneficial to 
establish a universal timeframe for brachial artery baseline measurement during FMD 
assessment. Still, there is conflicting evidence concerning the effect of baseline selection 
on reported FMD (Thijssen et al., 2008; Ostrem et al., 2015; Ostrem et al., 2016). 
Historically, a pre-occlusion baseline has been utilized to calculate vessel response to 
reactive hyperemia (Corretti et al., 2002; Thijssen et al., 2011). However, the current 
study has demonstrated a high reproducibility of the post-occlusion vessel diameter. 
Theoretically, consideration of a post-occlusion diameter when determining peak FMD 
would be logical if the goal is to assess the total shear stress-mediated vessel change, 
since the post occlusion baseline may be the smallest brachial artery diameter in a 
majority of individuals. Therefore, the use of a post-occlusion baseline may give a better 
indication of true dilation capacity. However, the absolute diameter change from 
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occlusion baseline, or pre-occlusion baseline, to H-FMC could also be an ancillary 
measure of endothelial health.  
Currently, it is unknown if, and to what degree, H-FMC is correlated with the 
development of atherosclerosis and cardiovascular disease. Previously, individuals 
displaying an H-FMC have significantly lower FMD measures compared to Non-H-FMC 
individuals (Ostrem et al., 2015; Ostrem et al., 2016). Historically, a reduced FMD 
response is considered a sign of endothelial dysfunction, as seen in individuals with 
greater severity of coronary artery stenosis (Kaku et al., 1998). However, Dobrosielski 
and colleagues (2006) reported that older males had less post-occlusion brachial artery 
constriction compared to young males. Therefore, H-FMC may be an indicator of vessel 
distensibility, reflecting mainly the elasticity of the vessel (Hoeks et al., 1990). 
Considering such a large number of children, adolescents and adults have displayed an H-
FMC in previous studies (Dobrosielski et al., 2006; Ostrem et al., 2015; Ostrem et al., 
2016) in conjunction with the current study’s healthy young adult population, it could be 
postulated that an H-FMC may serve as an ancillary representation of healthy endothelial 
function and increased vessel distensibility. Thus, it may be beneficial to assess H-FMC 
in a longitudinal cohort to fully comprehend the correlation with atherosclerosis and 
cardiovascular disease.  
There are some limitations to the present study. Only 10% of the study population 
(3 individuals) was consistently classified as Non-H-FMC individuals. This is contrary to 
previously reported frequencies in a cross-sectional study for an adult population (31%) 
(Ostrem et al., 2016). However, this discrepancy is most likely due to a disparity in 
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sample size between the previous and current studies. Also, menstrual cycle phase was 
not controlled for in women; however, this could only affect inter-day reproducibility 
and, theoretically, would not affect intra-day reproducibility. 
In conclusion, H-FMC presence and diameter are very reproducible both intra- 
and inter-day in young adults. The findings of this study further support consideration of 
an extended time period of analysis during FMD technique, one that includes the 
response of the artery immediately following occlusion. Constriction diameter and H-
FMC may be relevant not only in the comparison between various groups of individuals 
but also longitudinal studies interested in treatment or examination of CVD development. 
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TABLE LEGENDS 
Table 1. Physical and Vascular Characteristics 
Table 2. Intra- and Inter-day Comparisons for Vessel Diameter and Blood Flow 
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 Table 1. Physical and Vascular Characteristics  
 Male Female P-value 
N 15 15  
Age, years 24±3 24±3 0.525 
Height, cm 180.3±5.9 166.9±7.1 <0.001 
Total Body Mass, kg 81.2±14.5 60.2±12.6 <0.001 
BMI, kg/m
2
 24.9±3.6 21.5±3.6 0.016 
Waist Circumference, cm 81.5±8.1 69.6±10.0 0.002 
SBP, mmHg 118±10 109±7 <0.001 
DBP, mmHg 64±7 63±6 0.186 
Heart Rate, bpm 55±8 55±9 0.908 
 Note: Values are means±SD;  
BMI – Body Mass Index 
SBP – Systolic Blood Pressure 
DBP – Diastolic Blood Pressure 
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  Table 2. Intra- and Inter-day Comparisons for Vessel Diameter and Blood Flow 
 
Visit 1 Visit 2 
 
Test 1 Test 2 Test 1 Test 2 
Baseline Brachial 
Artery Diameter, mm 
 
3.70±0.67 
 
3.73±0.70 
 
3.68±0.65 
 
3.64±0.66 
H-FMC Diameter, mm 3.66±0.67 3.69±0.69 3.63±0.64 3.61±0.66 
H-FMC, % -1.12±1.74 -1.14±1.18 -1.29±1.31 -0.80±1.50 
Peak Shear, sec
-1
 225.2±65.7 215.5±75.6 225.9±79.7 217.5±78.4 
Maximal Flow, m/s 0.80±0.19 0.76±0.18 0.79±0.22 0.76±0.21 
Note: Values are means±SD; * denotes <0.05 significance 
H-FMC – High-Flow-Mediated Constriction 
 
 
 
 
 
 
 
 
 
 
 
  51 
Figure Legend 
Figure 1. A theoretical representation of a Flow-Mediated Dilation (percent change in 
brachial artery diameter from baseline) response in High-Flow-Mediated Constriction () 
and Non-High-Flow-Mediated Constriction () adults. 
Figure 2. Study protocol, High-Flow-Mediated Constriction diameter reproducibility.  
Figure 3. Bland-Altman plots for intra-day (A,B) and inter-day (C,D) difference in High-
Flow-Mediated Constriction diameter in young adults. 
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Figure 3 
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SUMMARY 
Purpose: When assessing vasomotor endothelial function by reactive hyperemia, the 
brachial artery, in some individuals, constricts immediately before beginning to dilate 
following cuff release. We call this response high-flow-mediated constriction (H-FMC). 
The aim of this study was to describe the frequency of the H-FMC during reactive 
hyperemia in children and adolescents throughout a range of body mass index (BMI) 
values, and to investigate differences in flow-mediated dilation (FMD), cardiovascular, 
and anthropometric measures between subjects with and without H-FMC.  
Methods: FMD was assessed in 136 children and adolescents (61 male, 75 female; 13±3 
years) by sonographic imaging of the brachial artery. H-FMC was characterized as the 
lowest point from the baseline brachial artery diameter immediately following reactive 
cuff release. Independent t-tests were used to compare subjects with and without H-FMC.  
Results: H-FMC was observed in 91 of the 136 participants (66.9%). No significant 
difference was found between H-FMC and non-H-FMC subjects for age (P=0.602), 
gender (P=0.767), height (P=0.227) or weight (P=0.171). BMI percentile was 
nonsignificantly higher (91.8
th
±14.9
th
vs.84.6
th
±22.8
th
 percentile, P=0.057) and FMD was 
significantly lower (5.43±3.41vs.8.05±3.97%, P<0.001) in H-FMC than in non-H-FMC 
subjects. Adding H-FMC to FMD produced no significant difference between H-FMC 
and non-H-FMC individuals (8.03±3.27%vs.8.05±3.97%, P=0.977).  
Conclusion: Approximately 67% of participants demonstrated an H-FMC during 
reactive hyperemia. BMI percentile was nonsignificantly higher and FMD was 
significantly lower in children and adolescents who displayed this phenomenon. 
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INTRODUCTION 
Flow-mediated dilation (FMD) is widely used as a noninvasive method for 
measurement of endothelial function through sonographic imaging of the brachial artery 
following reactive hyperemia (Corretti et al., 2002). Endothelial dysfunction has been 
associated with cardiovascular events (Deanfield, Halcox & Rabelink, 2007) as well as 
increasing age (Celermajer et al., 1994), gender (Kapuku et al., 2004; Juonala et al., 
2008), cigarette smoking (Lekakis et al., 1998), and obesity (Tounian et al., 2001; 
Williams et al., 2005). An increase in shear stress via increased flow has been thought to 
initiate endothelial nitric oxide (NO) synthase production and subsequent release of NO 
(Corson et al., 1996; Pyke & Tschakovsky, 2005). A delayed arterial dilatory response to 
shear stress has been observed in radial (Jiang et al., 2011), brachial (Corretti et al., 2002) 
and femoral (Kooijman et al., 2008) vascular beds. In the radial artery, a relatively recent 
study (Jiang et al., 2011) concluded that, during high blood flow, an opposing 
vasoconstrictor stimulus conceals the shear stress-induced NO-mediated dilation. It was 
postulated that vasoconstriction could result from the decrease in transmural pressure 
produced by the sudden fall in downstream flow resistance and/or by a shear stress-
stimulated constrictor release such as endothelin-1 (Jiang et al., 2011; Kuchan & Frangos, 
1993). 
A delayed dilation response is regularly observed in humans (Corretti et al., 2002; 
Corretti, Plotnick & Vogel, 1995; Black et al., 2008). However, immediately following 
the cuff release, the arteries of some individuals constrict before they begin to dilate. This 
physiological response has been referred to as a flow-mediated constriction (FMC) 
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(Figure 1) (Jiang et al., 2011; Rubanyi & Gabor, 1995; Turner, 2011; Gori et al., 2008). 
An alternative method for assessing the vascular function has been proposed by 
measuring the radial artery constriction during distal occlusion (Gori et al., 2008). This 
procedure has been termed low-flow-mediated constriction (L-FMC) (Gori et al., 2008). 
In contrast, a high-flow-mediated constriction (H-FMC) has been observed in healthy 
adults at the radial artery following occlusion (Jiang et al., 2011).
 
However, we found no 
report in the literature regarding the occurrence of brachial artery H-FMC in children and 
adolescents.  The aim of the present study was to assess the rate of brachial artery H-
FMC during reactive hyperemia in children and adolescents throughout a large range of 
body mass index (BMI) values, and to investigate differences in FMD, and hemodynamic 
and anthropometric measures, between those subjects who experience this phenomenon 
and those who do not. 
 
MATERIALS AND METHODS 
 
Study Population 
One hundred thirty-six children and adolescents (61 males, 75 females) were 
assessed for peak FMD. Subjects were recruited from a pediatric weight management 
clinic (patients and siblings) and from the community via flyers and advertisements. The 
study protocol was reviewed and approved by the University of Minnesota Institutional 
Review Board and all participants, along with parents/guardians, gave written informed 
assent and consent. The procedures followed in the study were in accordance with the 
institutional review board and HIPAA guidelines. Subjects were fasted for at least 8 
hours prior to vascular assessment and were asked to abstain from caffeine for at least 4 
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hours on the morning of testing. Avoidance of strenuous exercise or physical activity was 
also required for 24 hours prior to the study visit. 
 
Physical Assessments 
Measurements for height and weight were obtained with a standard stadiometer 
(Avrton, Model S100, Prior Lake, MN) and electronic scale (ST Scale-Tronix, Serial No. 
5022-8893, White Plains, NY), respectively. BMI was calculated as weight in kilograms 
divided by height in meters-squared. Tanner stage was assessed by a trained pediatrician 
or registered nurse. Waist and hip circumferences (in centimeters) were obtained with a 
Gulick measuring tape (Creative Health Products, Ann Arbor, MI). 
 
Vascular Assessments 
Vascular testing was performed in the Vascular Biology Laboratory in the 
Clinical and Translation Science Institute at the University of Minnesota. Subjects were 
tested in a quiet, climate-controlled room (22-23°C). Resting blood pressure was 
recorded using an automated sphygmomanometer (Colin Medical Instruments Corp., San 
Antonio, TX) on the right arm prior to FMD assessment. A blood pressure cuff was also 
placed on the left forearm. Following 15 minutes of quiet rest in the supine position, 
vascular images of the left brachial artery were obtained proximal to the antecubital fossa 
in the longitudinal plane using a conventional ultrasound scanner (Acuson, Sequoia 512, 
Siemens Medical Solutions USA, Inc., Mountain View, CA) with a 8-15 MHz linear 
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array probe held at a constant pressure on the skin and at a fixed point over the imaged 
artery by a stereotactic arm.  
The blood pressure cuff on the left forearm was inflated to a suprasystolic 
pressure level of 200 mmHg and maintained for 5 minutes. Vascular images were 
captured 20 seconds prior to cuff release until 3 minutes post-cuff release and were 
digitized and stored on a personal computer for later off-line analysis using an electronic 
wall-tracking software program (Vascular Research Tools 5, Medical Imaging 
Application, LLC, Iowa City, IA). Vascular images were assessed and baseline brachial 
artery measurements were recorded as a 10-second average just prior to blood pressure 
cuff release (i.e. occlusion baseline), and a 10-second average immediately following 
blood pressure cuff release. Peak dilation during each study was defined as the 10-second 
average of the greatest percent change from baseline brachial artery diameter. Shear rate 
was used to estimate shear stress and calculated as blood flow velocity divided by arterial 
diameter. The maximal flow 10-second average blood flow after cuff release was 
reported as maximal flow. The H-FMC was characterized using a 10-second average of 
the lowest point from baseline brachial artery diameter following cuff release and 
considered present if the diameter increased by less than -0.1% or decreased (Figure 1). A 
trained sonographer performed all digital sonographic image analysis. When FMD was 
measured 7 days apart, the coefficient of variation was 11.1% in our laboratory, 
demonstrating good reproducibility. 
 
 Statistical Analysis 
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Statistical analysis was performed using IBM SPSS Statistics 21 (IBM Corp. 
Released 2012. IBM SPSS Statistics for Windows, Version 21.0; IBM Corp., Armonk, 
NY). Descriptive statistics were conducted for the two groups on anthropometric and 
hemodynamic measurements. Independent t-tests were used to compare differences 
between subjects who demonstrated an H-FMC and those who did not. A correlation 
matrix between analyzed parameters was implemented among significant anthropometric 
and vascular measures. A one-way analysis of variance was conducted for the degree of 
H-FMC for BMI percentile. An α value of 0.05 was denoted as statistically significant.  
 
RESULTS 
Mean demographic characteristics of children are presented in Table 1. Of the 136 
children and adolescents examined in this study, 91 (66.9%) displayed an H-FMC. 
Children and adolescents ranged in age from 8 to 17 years old, with a mean age of 13±3 
years. When classified by BMI percentile, 70.6% of the study population was considered 
obese, 9.5% overweight and 19.9% were normal weight for their age and gender. When 
grouped by the presence or absence of H-FMC according to BMI percentile, 70.8% of 
obese and 76.9% of overweight children and adolescents displayed an H-FMC versus 
48.1% of normal weight children and adolescents. Comparing BMI percentile within the 
H-FMC group and degree of H-FMC, average constriction was significantly greater in 
normal weight individuals than in both overweight and obese combined (-3.53±1.88% vs. 
-2.45±1.59%, P=0.03). No differences were observed for composition of gender, levels of 
systolic and diastolic blood pressure, heart rate, height, weight, BMI, Tanner stage, or hip 
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and waist circumference (Table 1). BMI percentile was nonsignificantly higher in H-
FMC than in non-H-FMC children and adolescents (Table 1). Table 2 displays the 
vascular measures for the study population. Baseline brachial artery diameter, average 
shear, peak shear and maximal flow were not significantly different between H-FMC and 
non-H-FMC children and adolescents. Peak FMD was significantly lower in H-FMC 
individuals than in non-H-FMC.  
A correlation matrix was constructed using FMD, H-FMC, BMI and BMI 
percentile values. A greater H-FMC was associated with lower peak FMD (r=0.455, 
P<0.001). Peak FMD was positively correlated with BMI (r=0.243, P=0.004) and BMI 
percentile (r=0.234, P=0.006). A greater H-FMC was not significantly correlated with 
increased BMI (r=-0.006, P=0.949) or BMI percentile (r=-0.066, P=0.442). A one-way 
analysis of variance for degree of H-FMC revealed no significant difference between or 
within groups based on BMI percentile (P=0.92). 
 
DISCUSSION 
The aim of the study was to examine the prevalence of early FMC during reactive 
hyperemia in normal weight, overweight and obese children and adolescents and 
investigate potential differences of anthropometric and hemodynamic measures in 
relation to its presence. We found that approximately 67% of the population displayed H-
FMC.  Those individuals who displayed H-FMC had a lower peak FMD compared to 
individuals that did not. 
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Jiang et al. (2011) suggested two explanations for transient initial constriction 
following cuff release: 1) an FMC factor or 2) a reduction in intra-arterial pressure 
resulting from the fall in downstream resistance that, in turn, led to increased flow.  An 
argument could be made that non-H-FMC children and adolescents could possibly have a 
blunted shear-stimulated release of a constrictor agent, such as endothelin-1 (Jiang et al., 
2011; Kuchan & Frangos, 1993). If this were true, one would expect a difference in the 
time to peak between H-FMC and non-H-FMC groups, which there was not. A blunted 
shear stress release of vasoconstrictors such as endothelin-1 could, theoretically, be due 
to a higher level of shear stress in non-FMC before cuff release, since high levels of shear 
stress have been shown to suppress endothelin-1 release in cultured endothelial cells 
(Kuchan & Frangos, 1993). However, in the present study, there was no significant 
difference in shear stress or maximal flow between subjects who displayed an H-FMC 
and those who did not.  
Another possible explanation may be that H-FMC children have a higher 
sensitivity to endothelin-1. Research by Weil et al. (2011) in adults supports the notion 
that overweight and obesity are associated with enhanced endothelin-1 mediated 
vasoconstriction. Enhanced constriction could contribute to endothelial vasodilator 
dysfunction and to the increase risk of hypertension in these subjects. In the present 
study, 85.7% of H-FMC children and adolescents were categorized as overweight or 
obese versus 68.8% of the non-H-FMC. Those demonstrating H-FMC to had a 
nonsignificantly greater BMI percentile, which may support the hypothesis of the release 
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of FMC factor following cuff release. However, H-FMC and BMI percentile were not 
significantly correlated. 
A significant drop in intra-arterial pressure may also be responsible for H-FMC. 
Reactive tissue hyperemia is due to the buildup of metabolic by-products during 
ischemia, inducing vasodilation of “resistance” arteries (at the microcirculation level). 
The resulting fall in circulatory resistance led to increased blood flow in the “conduit” 
artery upstream, so that its own resistance to flow may become significant (at least until 
its own vasodilation occurs) and create a pressure loss, which may cause its passive 
mechanical constriction (recoil). However, all things being equal, this response should 
have been observed in all subjects because the methodology was identical for H-FMC 
and non-H-FMC children and adolescents. Differences in amplitude of tissue hyperemia 
and/or in baseline conduit artery diameter might explain various degrees of imbalance 
between these opposite mechanisms, with H-FMC occurring when greater hyperemia 
and/or smaller conduit artery baseline diameter led to a larger pressure drop. This, in turn, 
would result in a greater, although delayed, FMD, which we could not observe in the 
present study. Moreover, we found no significant difference in shear stress or maximal 
flow between subjects who displayed an H-FMC and those who did not, and children and 
adolescents with an H-FMC had a significantly lower FMD than those without. 
Therefore, some release of endothelin-1 cannot be ruled out.  
FMD has been utilized as a predictor of cardiovascular events in asymptomatic 
subjects (Thijssen et al., 2011). Overweight and obese children have displayed impaired 
FMD values (Meyer et al., 2006) and are at increased risk for developing coronary heart 
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disease risk factors (Freedman et al., 1999). Higher FMD is generally associated with 
healthy endothelial function, and in the present study, non-H-FMC children and 
adolescents displayed brachial artery FMD levels similar to levels of healthy control 
subjects in other studies
 
(Babar et al., 2011). Even though the presence of an H-FMC was 
associated with lower FMD response, it is unclear whether the H-FMC is associated with 
other cardiovascular risk factors. This will need to be examined in future studies. 
Of interest, when an addition of the percentage of H-FMC to peak FMD is applied 
to those displaying a vasoconstriction, the difference in peak FMD between the two 
groups disappears. It seems that there is a limited timeframe during which peak dilatory 
response to reactive hyperemia occurs.  Therefore, if the initial response to cuff release is 
constriction, the result will lower the overall dilation of the brachial vessel relative to the 
initial baseline diameter.  Statistical difference has been observed in the current study 
between the two groups for the composite end point and FMD values (Table 2). H-FMC 
may have similar complementary value to FMD as L-FMC, which was shown to have 
further value than a composite value (FMD+L-FMD) by reducing false-positive and 
false-negative results when used independently of FMD in clinical applications 
(Humphreys et al., 2014; Gori et al., 2010).
 
Not only does the presence of an H-FMC 
complicate the analysis of FMD but it also adds to the body of FMD research. The time 
course for dilation for both groups is similar, which seems to imply that NO and other 
dilating factors are secreted for a set amount of time in children and adolescents.  BMI 
may also have an effect on the prevalence of vasoconstriction observed after occlusion, 
with H-FMC being a possible independent indicator of vascular change. Since obesity is 
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often associated with endothelial dysfunction (Tounian et al., 2001; Williams et al., 
2005), the presence  of a H-FMC may be an initial sign of vascular dysfunction, as there 
was a moderate correlation between H-FMC and FMD but with BMI or BMI percentile.  
However, this hypothesis will need to be examined in future studies.   
Previous research has investigated ancillary measures to FMD. L-FMC has been 
documented as a response of the radial artery during distal occlusion (Gori et al., 2008; 
Gori et al., 2010). This measure provides an accurate measure of resting arterial tone as it 
assesses the arterial response to resting shear stress (Gori et al., 2008; Gori et al., 2010). 
However, the technique reported for measuring L-FMC is vastly different compared to 
H-FMC. Weissgerber et al. (2010)
 
reported that L-FMC was observed in the radial artery 
but not in the brachial artery of healthy pregnant and nonpregnant women. It would 
appear that L-FMC in the brachial artery is not as uniform a response as the radial artery. 
A significant increase in brachial artery diameter during cuff occlusion was observed in 
healthy children and young adults (Thijssen et al., 2008). Not only does the imaged 
vascular bed differ but also the time course of the constriction is different. L-FMC 
measures constriction during blood flow restriction while H-FMC is the constriction 
observed immediately following occlusion release. Brachial artery H-FMC may have a 
comparable benefit on cardiovascular health assessment as L-FMC of the radial artery. 
The present study is subject to a few limitations. Intra-arterial pressure and 
vasoconstrictor mediators were not directly measured. Since many of the participants 
were recruited from a pediatric weight management clinic (in addition to the community), 
the percentage of overweight and obese children in this study was much higher than in 
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the general pediatric population.  Future studies could investigate children with lower 
BMI values for the presence and rate of an H-FMC as well as the prevalence of an H-
FMC in differing adult populations. Investigation of health risk factors possibly 
associated with an H-FMC would also be beneficial. In addition, assessment of L-FMC 
would be beneficial when assessing FMD and H-FMC in future studies. A prospective 
study would be required to determine the validity and reliability of H-FMC as a risk 
factor for atherosclerosis and cardiovascular disease. 
 
CONCLUSION 
We observed an H-FMC in a majority of overweight and obese children and 
adolescents during reactive hyperemia. FMD was lower in children and adolescents who 
experience this phenomenon, suggesting the presence of endothelial dysfunction. 
Whether H-FMC has any clinical implications is currently unknown. However, our 
findings suggest that this phenomenon should be considered when analyzing and 
interpreting FMD data. Future studies should examine the relationship of the presence of 
H-FMC with cardiovascular risk factors in children and adults. 
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TABLE LEGENDS 
Table 1. Demographic Characteristics 
Table 2. Measures of Vascular Function 
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Table 1. Demographic Characteristics  
 H-FMC Non-H-FMC P-value 
n (% male) 91 (44%) 45 (47%)  
Age, years 13.0±2.5 12.8±2.7 0.602 
Blood pressure, mmHg    
Systolic 118±12 117±13 0.849 
Diastolic 61±9 60±8 0.480 
Height, cm 158.8±12.1 155.9±14.5 0.227 
Weight, kg 76.9±26.4 70.3±26.3 0.171 
Tanner Stage 3±1 3±1 0.477 
Hip Circumference, cm 100.5±16.3 97.4±17.4 0.308 
Waist Circumference, cm 87.2±16.7 83.5±17.8 0.235 
Body Mass Index, kg/m
2
 29.8±7.5 27.8±7.8 0.151 
Body Mass Index Percentile,  91.8±14.9 84.6±22.8 0.057 
Note: Values are means±SD; n, number of participants/group. 
H-FMC – High-Flow Mediated Constriction 
Non-FMC – No High-Flow Mediated Constriction 
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Table 2. Measures of vascular function  
 H-FMC Non-H-FMC P-value 
Brachial Artery Diameter, mm 3.33±0.44 3.24±0.40 0.296 
Time to Peak FMD, sec 59.0±24.3 62.1±34.3 0.591 
Average Shear, sec
-1
 262.5±62.1 273.7±61.1 0.321 
Peak Shear, sec
-1
 294.4±74.6 301.5±65.6 0.589 
Maximal Flow, m/s 0.85±0.18 0.89±0.17 0.168 
Brachial Artery Peak 
Diameter, mm 
3.56±0.47 3.55±0.40 0.826 
Flow-Mediated Dilation, % 5.43±3.41 8.05±3.97 <0.001 
H-FMC+FMD, % 8.03±3.27 8.05±3.97* 0.977 
Note: Values are means±SD; *Non-H-FMC is the same for FMD and H-FMC+FMD 
Maximal flow (m/s) is a measure of average blood flow following cuff release. 
FMD – Flow Mediated Dilation  
H-FMC – High-Flow Mediated Constriction  
Non-FMC – No High-Flow Mediated Constriction 
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FIGURE LEGEND 
Figure 1. A representation of a Flow-Mediated Dilation (percent change in brachial 
artery diameter from baseline) response in H-FMC () and Non-H-FMC () children.   
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Figure 1 
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CHAPTER 5. HIGH-FLOW MEDIATED CONSTRICTION IN ADULTS IS NOT 
INFLUENCED BY BIOMARKERS OF CARDIOVASCULAR AND METABOLIC 
RISK 
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Summary 
Purpose: During reactive hyperemia, the brachial artery in some individuals constricts 
prior to dilation. The aim of this study was to describe the frequency of high-flow-
mediated constriction (H-FMC) in adults, and relationship of H-FMC to body 
composition and biomarkers of cardiovascular and metabolic risk. 
Methods: 246 adults (124 male, 122 female; 36±7 years) were assessed for H-FMC via 
ultrasound imaging of the brachial artery. Blood pressure, glucose, insulin, lipids, and 
body composition assessed via dual energy X-ray absorptiometer were collected for each 
participant. H-FMC was characterized as a 10-second average of maximal post-occlusion 
constriction. Independent t-tests were used to compare variables between H-FMC vs. 
Non-H-FMC individuals.  
Results: H-FMC was observed in approximately 69% of adult participants (54 obese, 57 
overweight, and 59 normal-weight). Total body mass (82.3±17.5vs.76.3±16.3kg, 
P=0.012), fat mass (27.7±11.5vs.23.8±10.5kg, P=0.012), body mass index 
[BMI:27.7±4.9vs.26.1±5.0kg/m
2
, P=0.018], and low-density lipoprotein to high-density 
lipoprotein ratio [LDL/HDL:2.41±1.03vs.2.09±0.72, P=0.007] were significantly higher 
in H-FMC compared to Non-H-FMC individuals. FMD (6.12±3.48vs.8.09±3.02%, 
P<0.001) was significantly lower in H-FMC subjects. However, when H-FMC was added 
to FMD there was no significant difference in brachial artery dilation between groups 
(7.57±3.69vs.8.09±3.02%, P=0.250).  
Conclusion: Increased body mass, fat mass and BMI were associated with a greater H-
FMC. When H-FMC is present, the FMD response to reactive hyperemia is significantly 
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decreased. Since H-FMC has been observed to negatively affect FMD response to 
reactive hyperemia, it is suggested that H-FMC should be noted when analyzing and 
interpreting FMD data. H-FMC is an indicator of vascular change and may be an 
ancillary measure of endothelial health. 
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Introduction 
Cardiovascular disease (CVD) is the leading cause of death worldwide (Mendis et 
al., 2011). In 2008 over 75% of the 17.3 million CVD deaths were attributed to 
manifestations of atherosclerosis, an underlying process that narrows and hardens blood 
vessels (Mendis et al., 2011). Endothelial dysfunction has been shown to be an important 
precursor in the atherosclerotic process (Ross, 1993). Flow-mediated dilation (FMD) is 
widely used as a noninvasive method for measurement of endothelial health in children 
and adults (Corretti et al., 2002).  
Previously, we have reported that 67% of children demonstrate vasoconstriction 
prior to a shear stress-induced nitric oxide (NO)-mediated dilation of the brachial artery 
during an FMD assessment (Ostrem et al., 2015). The opposing vasoconstrictor stimulus 
produces a biphasic response when plotting the diameter change of an artery in response 
to reactive hyperemia (Figure 1). This physiological response has been referred to as a 
high-flow-mediated constriction (H-FMC) (Jiang et al., 2011; Ostrem et al., 2015). It has 
been postulated that the observed vasoconstriction could result from a hemodynamic 
effect of increased blood flow leading to decreased transmural pressure and/or a shear 
stress-stimulated constrictor release, such as endothelin-1 (Dobrosielski et al., 2006; 
Jiang et al., 2011; Kuchan & Frangos, 1993; Ostrem et al., 2015; Turner, 2011).  
This biphasic response of the brachial artery has previously been reported in adult 
males during reactive hyperemia (Dobrosielski et al., 2006). To our knowledge, no 
published work has reported on the frequency and magnitude of H-FMC observed at the 
brachial artery in a healthy adult male and female population or the impact of an H-FMC 
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on reported peak FMD. Additionally, the relationship of biomarkers of cardiovascular 
and metabolic health and H-FMC has not been elucidated. The presence of an H-FMC 
could possibly negatively affect peak FMD such that the response to reactive hyperemia 
in healthy individuals appears similar to individuals with endothelial dysfunction and 
increased cardiovascular risk (Neunteufl et al., 1997). The purpose of this study was to 
describe the frequency and magnitude of an H-FMC during reactive hyperemia in healthy 
adult males and females.  In addition, we sought to examine the relationship of H-FMC to 
FMD, biomarkers of cardiovascular and metabolic risk as well as measures of body 
composition. It is hypothesized that an H-FMC affects peak FMD and is significantly 
correlated with body composition as well as known cardiovascular and metabolic risk 
factors.  
 
Materials and Methods 
Study Population 
The 246 adults (124 males, 122 females) in this study were randomly sampled 
from two population based longitudinal studies investigating the development of obesity 
and insulin resistance and their interaction with associated cardiovascular risk factors 
(Dengel et al., 2011; Marlatt et al., 2013). Subjects who smoked or were taking 
prescription medications, such as blood pressure, insulin, dyslipidemia or statin 
medication, were excluded from the study. The study protocol was reviewed and 
approved by an institutional review board, and all participants gave written informed 
consent. 
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Physical Assessments 
Measurements for height and weight were obtained with a standard stadiometer 
(Avrton, Model S100, Prior Lake, MN, USA) and electronic scale (ST Scale-Tronix, 
Serial No. 5022-8893, White Plains, NY, USA), respectively. Body mass index (BMI) 
was calculated as weight in kilograms (kg) divided by height in meters-squared (m
2
). 
 
Dual-energy X-ray Absorptiometry  
 Body composition was measured using a dual energy X-ray absorptiometer 
(DXA) (GE Healthcare Lunar iDXA, platform version 13.6, GE Healthcare Lunar, 
Madison, Wisconsin, USA). The total body scan was analyzed using the enCore
TM
 
CoreScan software. Standard imaging and positioning protocols were implemented while 
subjects were fasted and hydrated. Proprietary software algorithms from the manufacturer 
were used to segment and analyze the body into upper and lower extremities using the 
standard regions of interest (ROI) and then combined for each of the measures of interest: 
lean mass, fat mass, visceral adipose tissue mass (VAT), android fat, gynoid fat, 
subcutaneous (subQ) fat, and bone mass. Android fat was calculated between the ribs and 
the top of the pelvis, while the gynoid fat was determined from the upper thighs to the top 
of the pelvis. The subQ fat was then calculated as the android fat–VAT mass. Each 
subject’s measure of interest was reported in kilograms (kg).  
 
Glucose, Insulin and Lipid Profile Assessment  
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 All assays were conducted with standard procedures at a Center for Disease 
Control and Prevention-certified laboratory. Fasting blood samples were collected for 
glucose, insulin and lipid levels including total cholesterol, triglycerides, high-density 
lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL). The 
LDL/HDL ratio was reported for each subject, because a higher ratio has been related to 
increased coronary heart disease risk (Fernandez & Webb, 2008). Homeostatic model 
assessment (HOMA) of insulin resistance and β-cell function were calculated using 
fasting plasma insulin and fasting plasma glucose (Matthews et al., 1985). 
 
Vascular Assessments 
 Vascular assessment was conducted for all participants following at least 8 hours 
of fasting. Subjects were required to refrain from caffeine ingestion within 4 hours prior 
to testing and avoid strenuous exercise or physical activity 24 hours prior to the study 
visit. Subjects were tested in a quiet, climate-controlled room (22-23°C). Resting blood 
pressure was recorded using an automated sphygmomanometer (Colin BP-8800, Colin 
Medical Instruments Corp., San Antonio, TX, USA) on the right arm prior to FMD 
assessment. A specialized occlusion cuff (D.E. Hokanson, Inc., Bellevue, WA) was 
placed approximately five centimeters (cm) distal to the antecubital space on the left 
forearm. Following 15 minutes of quiet rest in the supine position, vascular images of the 
left brachial artery were obtained proximal to the antecubital fossa in the longitudinal 
plane using a conventional ultrasound scanner (Acuson, Sequoia 512, Siemens Medical 
Solutions USA, Inc., Mountain View, CA, USA) with a 8-15 MHz linear array probe 
held at a constant pressure on the skin and at a fixed point over the imaged artery by a 
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stereotactic arm. The occlusion cuff on the left forearm was then inflated to a 
suprasystolic pressure level of 200 mmHg and maintained for 5 minutes. Vascular images 
were captured 20-seconds prior to cuff release until 3 minutes post-cuff release and were 
digitized and stored on a personal computer for later analysis using an electronic wall-
tracking software program (Vascular Research Tools 5, Medical Imaging Application, 
LLC, Iowa City, IA, USA).  
A trained sonographer performed all digital ultrasound image capturing and 
analysis. The coefficient of variation was 11.1% in our laboratory when FMD was 
measured 7 days apart, demonstrating good reproducibility. Vascular images were 
assessed for brachial artery baseline diameter, maximal blood flow, peak shear and 
subsequent brachial artery constriction and dilation.  The baseline brachial artery 
measurement was defined as a 10-second average just prior to blood pressure cuff 
release, i.e. occlusion baseline, to negate any low-flow mediated constriction that may 
occur during occlusion. Maximal blood flow (m/s) was defined as the largest 10-second 
average rate of blood flow following 3 seconds post-cuff release. Peak shear was used to 
estimate the greatest shear stress during the same timeframe as maximal blood flow. Peak 
shear was calculated as a 10-second average during post occlusive reactive hyperemia, 
which was calculated as blood flow velocity divided by arterial diameter. H-FMC was 
observed and characterized using a 10-second average of the lowest point from baseline 
brachial artery diameter following 3-seconds post cuff release and considered present if 
the percent change was less than -0.1% (Figure 1). Peak dilation during each procedure 
was defined as the 10-second average of the greatest percent change from baseline 
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brachial artery diameter. The time that elapsed between cuff release and greatest 
constriction in H-FMC individuals was recorded as time-to-trough FMC (TTT FMC). 
There was no observed constriction in Non-H-FMC individuals following cuff release, so 
TTT FMC was not applicable for the Non-H-FMC group. The time between cuff release 
and peak dilation was recorded as time-to-peak FMD (TTP FMD).  
 
 Statistical Analysis 
All statistical analysis was performed using IBM SPSS Statistics 22 (IBM Corp. 
Released 2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM 
Corp.). Descriptive statistics were conducted for the two groups on anthropometric, 
biomarkers of cardiovascular and metabolic risk, and FMD measurements. Allometric 
scaling was performed for H-FMC and FMD related to baseline brachial artery diameter 
as proposed by Atkinson and colleagues (Atkinson & Batterham, 2013; Atkinson et al., 
2013). Independent t-tests were used to compare variables between subjects who 
demonstrated an H-FMC vs. Non-H-FMC. An alpha value of 0.05 was denoted as 
statistically significant. A correlation matrix was then constructed which included 
significant body composition, biomarkers of cardiovascular and metabolic risk, and FMD 
measures that were differing between H-FMC and Non-H-FMC groups at a significance 
of P<0.05. A subgroup analysis of significant variables between groups was conducted 
within genders. 
 
Results 
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Mean demographic characteristics of adults are presented in Table 1. Adults 
ranged in age from 18 to 46 years old. Of the 246 adults examined in this study, 170 
(69.1%) displayed an H-FMC. A greater magnitude of H-FMC was positively associated 
with lower peak FMD (r=0.238, P<0.001).  No differences were noted between the two 
groups for gender composition (P=0.114), however, 73% of males and 65% of females 
displayed an H-FMC. Height, VAT mass and body fat percentage were not different 
between groups. Body mass index (BMI) of the study population ranged from 17.2 to 
39.3, with 79.4% of obese individuals, 65.5% of overweight individuals and 64.8% of 
normal-weight individuals displayed an H-FMC. Total body mass, BMI, fat mass, subQ 
fat, android fat, gynoid fat and bone mass were significantly higher in H-FMC adults 
compared to Non-H-FMC adults. Total body mass (r=-0.127, P=0.047) and BMI (r=-
0.140, P=0.028) were negatively associated with H-FMC. Fat mass (r=-0.119, P=0.063), 
subQ fat (r=-0.123, P=0.059), android fat (r=-0.091, P=0.164) and gynoid fat (r=-0.111, 
P=0.089) were not significantly associated with H-FMC.  
A subgroup analysis within genders was conducted on significantly correlated 
variables between H-FMC and Non-H-FMC groups. There was not a significant 
correlation within males for total body mass (r=-0.039, P=0.669), BMI (r=-0.059, 
P=0.515), fat mass (r=-0.023, P=0.802), or subQ fat (r=-0.053, P=0.567) with H-FMC. 
However, significant correlations were found for total body mass (r=-0.205, P=0.024), 
BMI (r=-0.205, P=0.024), fat mass (r=-0.217, P=0.016), and subQ (r=-0.202, P=0.030) 
with H-FMC in females.  
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The comparison of the blood pressure and blood profile between H-FMC and 
Non-HFMC groups is represented in Table 2. There was no significant difference 
between groups for systolic and diastolic blood pressure, glucose, insulin, HOMA, total 
cholesterol, triglycerides, HDL or LDL. However, LDL/HDL was significantly elevated 
in H-FMC subjects compared to Non-H-FMC subjects (Table 2), but not significantly 
correlated to H-FMC (r=-0.111, P=0.087). 
Table 3 displays the study population’s vascular measures. Baseline brachial 
artery diameter in H-FMC individuals was not significantly different from Non-H-FMC 
individuals. In H-FMC individuals, the average TTT FMC was 10.2±4.9 seconds. Peak 
shear, maximal flow and TTP FMD were not significantly different between H-FMC and 
Non-H-FMC adults. Peak FMD response was significantly greater in Non-H-FMC 
individuals and did not change when using allometric scaling. However, when the 
magnitude of H-FMC was added to FMD in the H-FMC group, there was no longer a 
significant difference is response to reactive hyperemia (7.57±3.69 vs. 8.09±3.02, 
P=0.250). Peak FMD was negatively correlated with total body mass (r=-0.197, 
P=0.002), and bone mass (r=-0.279, P<0.001). Gynoid fat (r=0.129, P=0.048) was 
positively associated with peak FMD. 
 
Discussion 
The purpose of the present study was to examine the prevalence of H-FMC during 
reactive hyperemia in healthy adults and to investigate potential differences of body 
composition, glucose, insulin, HOMA, lipids and FMD measures relative to H-FMC 
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presence and magnitude. We observed that approximately 69% of the study population 
displayed H-FMC.  Individuals that displayed an H-FMC had a lower peak FMD from an 
occlusion baseline compared to individuals not displaying an H-FMC. Also, H-FMC 
individuals had a significantly greater total body mass, BMI, fat mass, bone mass, 
android fat, gynoid fat, subQ fat and LDL/HDL compared to Non-H-FMC individuals. 
Previously we demonstrated that H-FMC prevalence in children and adolescents 
was approximately 67% (Ostrem et al., 2015), which is very similar to the prevalence 
observed in adults in the present study. The significant presence of an initial constrictive 
response to reactive hyperemia in these studies should alert researchers utilizing FMD 
methodology to the possibility of a blunted peak FMD when using a baseline artery 
diameter measured before occlusion cuff release. However, when an addition of the 
percent of H-FMC to peak FMD is applied, the difference in peak FMD between the two 
groups is negligible. This finding is consistent with our previous research in children and 
adolescents (Ostrem et al., 2015).
 
Addition of H-FMC may be a better measure of true 
NO-mediated dilation, since dilation would be assessed from the lowest artery diameter. 
Thus, researchers could use a baseline diameter measure that occurs after the occlusion 
cuff has been released. It would appear that an appropriate timeframe for calculation of a 
10-second average baseline diameter following occlusion would be between 5 to 15 
seconds, since the average TTT FMC was at 10 seconds. This is in contrast to previous 
research showing that using a universal baseline diameter calculated following occlusion 
cuff did not produce practical differences in FMD (Ostrem et al., 2015).
 
Flow-mediated 
dilation has been utilized as a measure of endothelial function and predictor of 
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atherosclerotic development (Halcox et al., 2009) and cardiovascular events in 
asymptomatic subjects (Thijssen et al., 2011).
 
A larger FMD response is generally 
associated with healthy endothelial function. In the current study, Non-H-FMC adults 
displayed brachial artery FMD levels similar to levels of healthy control subjects in other 
studies (Bots et al., 2005; Williams et al., 2005) while H-FMC individuals had a 
significantly lower FMD response. Even though the increased magnitude of an H-FMC 
was mildly associated with lower FMD response, it is unclear whether the H-FMC is an 
independent risk factor of endothelial dysfunction.
 
Age, blood pressure, peak shear, maximal flow and baseline brachial artery 
diameter were not significantly different between H-FMC and Non-H-FMC groups, also 
consistent with prior work in children (Ostrem et al., 2015). However, contrary to the 
findings in children and adolescents, total body mass and BMI were significantly higher 
in the adult H-FMC group. Since body composition was assessed by DXA in the present 
study and not in our previous research, more precise weight-related factors were found to 
be significantly higher in the adult H-FMC group: fat mass, android fat, gynoid fat, subQ 
fat and bone mass.  These data would suggest that body composition has a greater 
influence on H-FMC in adults compared to other cardiovascular and metabolic risk 
factors since the LDL/HDL ratio was the only significant cardiovascular or metabolic 
factor significantly different between groups. However, the correlation of total body mass 
and BMI with H-FMC are relatively weak. Previous research has demonstrated reduced 
FMD in abdominally obese individuals compared to lean individuals, suggesting 
impaired endothelial function associated with android fat (Davison et al., 2010; Williams 
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et al., 2005). Furthermore, modest increases in visceral fat, as opposed to subQ fat, have 
resulted in impaired endothelial function (Romero-Corral et al., 2010). However, android 
fat, gynoid fat and subQ fat were significantly elevated in the H-FMC group in the 
current study. Historically, gynoid and subQ fat have been considered to be lower health 
risks compared to VAT and android fat (Samsell et al., 2014). Lower extremity adiposity, 
specifically larger subQ thigh fat, has even been associated with lowering potential health 
risks (Snijder et al., 2005). A positive correlation was found between gynoid fat and 
FMD in the present study, which is consistent with the notion of gynoid fat lowering 
potential risk. An increased bone mass was also observed in the H-FMC group than the 
Non-H-FMC group. Since a greater percentage of obese subjects were in the H-FMC 
group, it would seem appropriate for there to be a significant difference in bone mass 
between groups due to the well-established positive effect that increased mechanical 
loading, via body weight, has on bone formation (Cao, 2011). Overweight and obesity 
has been associated with enhanced endothelin-1 mediated vasoconstriction (Weil et al., 
2011) and a large percentage of obese individuals in the current study displayed an H-
FMC. It may be possible that an H-FMC in some adults occurs due to increased presence 
of a flow-mediated constriction factor following cuff release. Since H-FMC was 
significantly correlated to an increased BMI and body mass, it could be possible that an 
enhanced endothelin-1 mediated response is partially involved in the H-FMC. However, 
endothelin-1 was not measured and both BMI and body mass have a relatively weak 
correlation with H-FMC. 
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Another point of interest in the current research is the lack of significant 
differences between groups for many known cardiovascular risk factors. Previous 
research has reported that many of the known cardiovascular risk factors, such as 
dyslipidemia (Sorensen et al., 1994), diabetes mellitus (Clarkson et al., 1996), 
hypertension (Benjamin et al., 2004) and central obesity (waist circumference and VAT) 
(Hashimoto et al., 1998; Parikh et al., 2009; Romero-Corral et al., 2010) can alter FMD. 
Of the known cardiovascular risk factors, the LDL/HDL ratio was the only non-weight-
related factor statistically significant between the H-FMC and Non-H-FMC groups. 
However, a larger LDL/HDL ratio has been reported to have a significant associated with 
increasing BMI (Wilsgaard & Arnesen, 2004). Therefore, it may be possible for the 
development of abdominal obesity to precede a decline in lipids or presence of other 
cardiovascular risk factors. 
In the current study, there was homogeneity of the study participants for many of 
the cardiovascular risk factors due to their healthy control status in the overarching study. 
This homogeneity of participants could be interpreted as a limitation. On the contrary, an 
H-FMC may be an independent factor for cardiovascular risk, because homogeneity of 
known cardiovascular risk did not hinder the observation of H-FMC and Non-H-FMC 
responses to reactive hyperemia. Instead, there were significant correlations between H-
FMC, total body mass and BMI with many other weight-related factors trending toward 
significance. Previous research has suggested that central obesity appears to precede the 
appearance of hypertension, glucose abnormalities, and dyslipidemia (Cameron et al., 
2008). Thus, H-FMC could possibly be either a complimentary health assessment tool to 
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FMD or an insignificant artifact. A greater understanding of H-FMC could be achieved 
with future longitudinal research that included H-FMC magnitude with FMD 
methodology. 
Of interest, when a subgroup analysis based on gender was conducted, all of the 
H-FMC correlations with body composition were not significant in males, but were 
significant in females. This could be due to hormonal differences expected between 
genders. However, the significant correlations found in females between body 
composition and H-FMC remained weak.  
It has been posed that FMD, and subsequently H-FMC, needs to be scaled to 
account for the reliance on baseline diameter in FMD calculation (Atkinson & Batterham, 
2013; Atkinson et al., 2013). However, when allometric scaling was performed in the 
current study, a change in significance between groups for FMD was not observed (Table 
3). Furthermore, allometric scaling of H-FMC did not adhere to the criteria outlined in 
previous research (Atkinson & Batterham, 2013; Atkinson et al., 2013). 
Historically, the benefit of FMD testing is the simplistic and noninvasive nature 
of the procedure. Taking into account the presence of an H-FMC does complicate the 
analysis of FMD, as does allometric scaling (Atkinson & Batterham, 2013; Atkinson et 
al., 2013), but it also adds to the body of FMD research. The time to reach peak dilation 
for both groups is similar, which seems to imply that endothelial NO and other dilating 
factors are secreted for a set amount of time in adults. Since body mass and BMI seem to 
have a significant, but weak, correlation with the prevalence of vasoconstriction observed 
post-occlusion, H-FMC may be a possible independent indicator of vascular remodeling. 
  91 
Obesity could be an extrinsic factor associated with endothelial dysfunction,
 
while an H-
FMC may be an intrinsic sign of vascular dysfunction. However, this hypothesis will 
need to be examined in future studies.  
The present study is subject to a few limitations. Intra-arterial pressure and 
vasoconstrictor mediators were not directly measured. The possibility of autonomic 
nervous system contribution to H-FMC was also not investigated. The cross-sectional 
nature of the study also does not answer the reproducibility of the H-FMC response to 
blood flow manipulation. Future studies could investigate both children and adult cohorts 
for the reproducibility in presence and magnitude of an H-FMC. Also, at-risk and 
diseased populations could be investigated for prevalence of an H-FMC. The 
investigation of inflammatory and other ancillary blood markers associated with an H-
FMC would also be beneficial. A prospective study would be required to determine the 
reproducibility, validity, and physiological modification of an H-FMC as a risk factor for 
atherosclerosis and cardiovascular disease. 
 
Conclusion 
An H-FMC occurs in a majority of healthy adults during reactive hyperemia and 
FMD was lower in adults who experience H-FMC, suggesting the presence of endothelial 
dysfunction. Since a greater percentage of children, adolescents (Ostrem et al., 2015) and 
adults seem to display an H-FMC following occlusion, a post-occlusion baseline may be 
worth consideration in future FMD technique. Increased body mass and BMI were 
associated with a greater H-FMC; however, it is currently unknown whether H-FMC has 
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any clinical implications. Nevertheless, our findings suggest that this H-FMC should be 
considered when analyzing and interpreting FMD data. Future studies should examine the 
reproducibility, validity, and reliability of H-FMC and changes in body composition, 
specifically body mass and fat mass, on H-FMC magnitude in children and adults.  
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Table 2. Blood Profile 
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 Table 1. Physical Characteristics  
 H-FMC Non-H-FMC P-value 
n (% male) 170 (54%) 76 (43%)  
Age, years 36.3±7.0 36.8±6.6 0.597 
Height, cm 172.0±11.7 170.9±11.7 0.483 
Total body mass, kg 82.3±17.5 76.3±16.3 0.012 
Body Mass Index, kg/m
2
 27.7±4.9 26.1±5.0 0.018 
Bone mass, kg 3.2±0.7 3.0±0.7 0.026 
Lean body mass, kg 51.4±11.4 48.7±11.5 0.086 
Fat mass, kg 27.7±11.5 23.8±10.5 0.012 
Body fat, % 34.2±10.3 32.1±10.6 0.145 
VAT mass, kg 0.89±0.71 0.74±0.68 0.122 
Android fat, kg 2.5±1.3 2.1±1.2 0.029 
Gynoid fat, kg 4.6±1.7 4.1±1.6 0.037 
SubQ, kg 1.6±0.8 1.4±0.8 0.023 
Note: Values are means±SD; n, number of participants/group; DXA, dual energy x-ray 
absorptiometry; H-FMC – High-Flow Mediated Constriction 
Non-FMC – No High-Flow Mediated Constriction 
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 Table 2. Blood Profile  
 H-FMC Non-H-FMC P-value 
SBP, mmHg 113±13 113±13 0.845 
DBP, mmHg 70±10 70±11 0.698 
Glucose, mgdL-1 101±13 99±11 0.205 
Insulin, mU/l 7.7±7.1 6.4±5.7 0.148 
HOMA1-IR 35.9±36.0 28.7±26.9 0.125 
HOMA1-%B 1.5±1.3 1.3±1.1 0.201 
Triglycerides, mgdL-1 130±103 117±103 0.407 
Total Cholesterol, mgdL-1 183±36 178±39 0.306 
HDL, mgdL-1 49±14 51±12 0.235 
LDL, mgdL-1 109±32 103±29 0.125 
LDL/HDL 2.41±1.03 2.09±0.72 0.007 
 
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein;  
H-FMC – High-Flow Mediated Constriction 
Non-FMC – No High-Flow Mediated Constriction 
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Table 3. Measures of vascular function 
 H-FMC Non-H-FMC P-value 
Brachial Artery Diameter, mm 3.80±0.74 3.65±0.64 0.095 
TTP FMD, sec 56.1±25.6 52.0±18.7 0.215 
Peak Shear, sec
-1
 267.0±120.5 255.1±97.1 0.450 
Maximal Flow, m/s 0.98±0.39 0.92±0.28 0.257 
Flow-Mediated Constriction, % -1.45±1.18 1.40±1.30 <0.001 
Flow-Mediated Dilation, % 6.12±3.48 8.09±3.02 <0.001 
Scaled* Flow-Mediated Dilation, %  6.56±3.73 8.67±3.23 <0.001 
Note: Values are means±SD;  
Maximal flow (m/s) is a measure of average blood flow following cuff release. 
TTP FMD - Time-to-Peak FMD from cuff release to peak dilation 
FMD – Flow Mediated Dilation  
H-FMC – High-Flow Mediated Constriction  
Non-FMC – No High-Flow Mediated Constriction 
*Scaled Flow-Mediated Dilation, % refers to Allometric scaling
14,15 
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Figure Legend 
Figure 1. A comparison of a Flow-Mediated Dilation (percent change in brachial artery 
diameter from baseline) response in H-FMC () and Non-H-FMC () adults. 
Figure 2. A scatter plot of the relationship between BMI and H-FMC in adults. 
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Figure 1. 
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Figure 2. 
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Research Results and Implications 
 Non-invasive assessment of endothelial function via FMD has been extensively 
studied since the technique’s inception. While brachial artery FMD has been shown to 
correlate with coronary artery endothelial function and has a positive correlation with 
endothelial health, studies concerning the H-FMC response during an FMD procedure are 
lacking. The present dissertation offers insight into understanding H-FMC by quantifying 
the H-FMC response in various populations during an FMD procedure in three separate 
studies with one common theme. The main findings of the three studies presented in this 
dissertation demonstrate the need for consideration of H-FMC during FMD analysis and 
the ease of implementing H-FMC analysis to FMD, as well as extending previous 
knowledge of H-FMC reproducibility in young adults and H-FMC presence in children, 
adolescents and adults. 
 First, the intra- and inter-day reproducibility of H-FMC in young adults was 
assessed. Results indicated that H-FMC presence and diameter were highly reproducible 
within and between visits. The findings support consideration of an extended time period 
of analysis during FMD technique, one that includes the response of the artery 
immediately following occlusion, specifically between 5-15 seconds post occlusion. 
Also, the use of an H-FMC diameter during the 5-15 seconds post occlusion as a baseline 
diameter should be considered.  
 Second, H-FMC presence was assessed in normal weight, overweight and obese 
children and adolescents. Results indicated that a majority of overweight and obese 
children and adolescents experience H-FMC during reactive hyperemia. Interestingly, 
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FMD was significantly lower in those that experienced H-FMC compared to children and 
adolescents that did not when calculating FMD from an occlusion baseline. However, 
when H-FMC was added to FMD in the H-FMC children and adolescents, no difference 
between groups was observed in overall dilation. While the exact mechanisms for H-
FMC are not clear, a greater amount of H-FMC could either support the presence of 
endothelial dysfunction or could provide information on vessel distensibility, as it is 
unclear whether H-FMC is beneficial or negative. The findings suggest that H-FMC 
should be considered when analyzing and interpreting FMD data in children and 
adolescents.   
 And finally, H-FMC presence and correlation to body composition, cardiovascular 
and metabolic measures was assessed in an adult population in the third and final study. 
The results of this study indicate similar vessel responses to reactive hyperemia as 
children and adolescents, with a majority of adults displaying H-FMC. Only increased 
body mass and BMI were associated with a greater H-FMC. It is unknown whether H-
FMC has any clinical implications, whether a sign of endothelial dysfunction or increased 
distensibility. Nonetheless, the findings suggest that H-FMC should be considered when 
analyzing and interpreting FMD information. 
 This dissertation establishes an argument that FMD analysis could be enhanced 
with the inclusion of H-FMC information. A majority of children, adolescents and adults 
display H-FMC and H-FMC was found to have acceptable intra- and inter-day 
reproducibility. 
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Future Research 
 While this dissertation demonstrates a large presence of H-FMC in children, 
adolescents and adults, future studies should include H-FMC information to FMD 
assessments to confirm these findings. Presently, it is unknown whether H-FMC has any 
clinical implications or if constriction diameter and H-FMC are relevant pieces of 
information in diseased populations. Specifically, longitudinal studies should examine the 
relationship of H-FMC and constriction diameter with cardiovascular risk factors and 
CVD development. Additionally, future studies in H-FMC should investigate the effect 
of treatments on H-FMC and constriction diameter in healthy and diseased populations. 
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